,datetime,title,source,link,sentiment_class,sentiment_score
0,10/19/2016 11:20:20 PM,BRIEF-Insulet says Patrick Sullivan elected chairman of board (PODD),Reuters,http://www.businessinsider.com/r-brief-insulet-says-patrick-sullivan-elected-chairman-of-board-2016-10,positive,0.9378615617752075
1,11/3/2016 9:36:25 PM,BRIEF-Insulet Q3 loss per share $0.05 from continuing operations (PODD),Reuters,http://www.businessinsider.com/r-brief-insulet-q3-loss-per-share-005-from-continuing-operations-2016-11,neutral,0.9721328020095825
2,2/17/2017 12:22:11 PM,BRIEF-Insulet announces positive results from feasibility study of diabetes drug (PODD),Reuters,http://www.businessinsider.com/r-brief-insulet-announces-positive-results-from-feasibility-study-of-diabetes-drug-2017-2,negative,0.9362865686416626
3,2/27/2017 10:36:13 PM,BRIEF-Insulet reports Q4 revenue $103.6 million (PODD),Reuters,http://www.businessinsider.com/r-brief-insulet-reports-q4-revenue-1036-million-2017-2,positive,0.9111723303794861
4,3/23/2017 12:45:00 PM,"Medical Instruments Stocks Under Scanner -- Waters, Integra LifeSciences, Insulet, and Cooper",PR Newswire,/news/stocks/medical-instruments-stocks-under-scanner-waters-integra-lifesciences-insulet-and-cooper-1001861690,positive,0.845649003982544
5,5/8/2017 10:12:04 PM,BRIEF-Insulet reports Q1 loss per share $0.17 (PODD),Reuters,http://www.businessinsider.com/r-brief-insulet-reports-q1-loss-per-share-017-2017-5,neutral,0.9641584753990173
6,5/12/2017 12:30:00 PM,"Research Reports Initiation on Healthcare Stocks -- Endologix, C. R. Bard, Insulet, and Vericel",PR Newswire,/news/stocks/research-reports-initiation-on-healthcare-stocks-endologix-c-r-bard-insulet-and-vericel-1002007753,positive,0.9404559135437012
7,6/8/2017 3:00:00 PM,Ascensia Diabetes Care Announces Strategic Alliance with Insulet Corporation to Connect CONTOUR(R)NEXT ONE BGMS and Omnipod Dash(TM) PDM,PR Newswire,/news/stocks/ascensia-diabetes-care-announces-strategic-alliance-with-insulet-corporation-to-connect-contour-r-next-one-bgms-and-omnipod-dash-tm-pdm-1002078433,negative,0.9170300960540771
8,6/8/2017 3:00:00 PM,Ascensia Diabetes Care Announces Strategic Alliance with Insulet Corporation to Connect CONTOUR®NEXT ONE BGMS and Omnipod Dash™ PDM,PR Newswire,/news/stocks/ascensia-diabetes-care-announces-strategic-alliance-with-insulet-corporation-to-connect-contour-next-one-bgms-and-omnipod-dash-pdm-1002078442,negative,0.9345011115074158
9,6/8/2017 3:00:00 PM,Ascensia Diabetes Care Announces Strategic Alliance with Insulet Corporation to Connect CONTOUR®NEXT ONE BGMS and Omnipod Dash™ PDM,PR Newswire,/news/stocks/ascensia-diabetes-care-announces-strategic-alliance-with-insulet-corporation-to-connect-contour-next-one-bgms-and-omnipod-dash-pdm-1002078514,negative,0.9345011115074158
10,6/12/2017 12:32:06 PM,BRIEF-Insulet presents positive omnipod horizon hybrid closed-loop study results in children (PODD),Reuters,http://www.businessinsider.com/r-brief-insulet-presents-positive-omnipod-horizon-hybrid-closed-loop-study-results-in-children-2017-6,negative,0.9311758279800415
11,6/21/2017 1:05:00 PM,"Medical Supplies Stocks on Investors' Radar -- Endologix, Microbot Medical, ConforMIS, and Insulet",PR Newswire,/news/stocks/medical-supplies-stocks-on-investors-radar-endologix-microbot-medical-conformis-and-insulet-1002111464,positive,0.9336423277854919
12,7/20/2017 10:18:05 PM,BRIEF-Insulet to assume distribution and commercial support for its Omnipod system in Europe (PODD),Reuters,http://www.businessinsider.com/r-brief-insulet-to-assume-distribution-and-commercial-support-for-its-omnipod-system-in-europe-2017-7,positive,0.7923198342323303
13,8/4/2017 12:20:00 PM,"Healthcare Stock Performance Review -- Endologix, Zimmer Biomet, Insulet, and C.R. Bard",PR Newswire,/news/stocks/healthcare-stock-performance-review-endologix-zimmer-biomet-insulet-and-c-r-bard-1002233467,positive,0.9289240837097168
14,8/10/2017 10:12:06 PM,BRIEF-Insulet Corp appoints two board of directors (PODD),Reuters,http://www.businessinsider.com/r-brief-insulet-corp-appoints-two-board-of-directors-2017-8,positive,0.9236549139022827
15,9/7/2017 12:25:00 PM,"Daily Technical Summary Reports on Medical Supplies Stocks -- Insulet, Microbot Medical, C.R. Bard, and Hill Rom",PR Newswire,/news/stocks/daily-technical-summary-reports-on-medical-supplies-stocks-insulet-microbot-medical-c-r-bard-and-hill-rom-1002349041,positive,0.9420273900032043
16,9/28/2017 12:27:04 PM,BRIEF-Insulet says $100 mln investment in Massachusetts will provide for hundreds of local jobs (PODD),Reuters,http://www.businessinsider.com/r-brief-insulet-says-100-mln-investment-in-massachusetts-will-provide-for-hundreds-of-local-jobs-2017-9,negative,0.9014058113098145
17,10/24/2017 11:19:00 PM,"Lifshitz & Miller LLP Announces Investigation of AcelRx Pharmaceuticals, Inc., Bob Evans Farms, Inc., Calgon Carbon Corporation, Exa Corporation, Insulet Corporation, K12 Inc., PG&E Corporation",PR Newswire,/news/stocks/lifshitz-miller-llp-announces-investigation-of-acelrx-pharmaceuticals-inc-bob-evans-farms-inc-calgon-carbon-corporation-exa-corporation-insulet-corporation-k12-inc-pg-e-corporation-1005493850,positive,0.7828422784805298
18,11/8/2017 1:42:03 PM,BRIEF-Insulet announces pricing of convertible senior notes due 2024 (PODD),Reuters,http://www.businessinsider.com/r-brief-insulet-announces-pricing-of-convertible-senior-notes-due-2024-2017-11,positive,0.9103947877883911
19,1/9/2018 2:52:01 AM,"CBMG Up 90% In 5 Days, ALDR Delivers On Promise, ABLX Being Pursued By NVO ",RTTNews,/news/stocks/cbmg-up-90-in-5-days-aldr-delivers-on-promise-ablx-being-pursued-by-nvo-1012696148,negative,0.9426348209381104
20,4/6/2018 2:55:18 PM,BRIEF-Insulet Corp Says CEO's 2017 Total Compensation Was $8.2 Mln Vs $6 Mln In 2016,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/hyKMsgjnsXM/brief-insulet-corp-says-ceos-2017-total-compensation-was-8-2-mln-vs-6-mln-in-2016-idUSFWN1RJ0DZ,neutral,0.9192070364952087
21,5/1/2018 11:37:04 PM,BRIEF-Insulet Establishes Two Significant Commercial Partnerships To Support Its European Expansion,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/_bxBjIzMzXY/brief-insulet-establishes-two-significant-commercial-partnerships-to-support-its-european-expansion-idUSFWN1S80MZ,negative,0.9250435829162598
22,5/3/2018 10:13:37 PM,BRIEF-Insulet Reports Q1 Loss Per Share $0.11,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/9C0IkLrUIY0/brief-insulet-reports-q1-loss-per-share-0-11-idUSASC09ZMP,neutral,0.9672497510910034
23,6/25/2018 2:51:33 PM,Eli Lilly: Humulin R U-500 Administered In Insulin Pump Shows Improved A1C ,RTTNews,/news/stocks/eli-lilly-humulin-r-u-500-administered-in-insulin-pump-shows-improved-a1c-1027314738,negative,0.9560748338699341
24,7/31/2018 3:02:53 PM,Here's what Wall Street expects from Insulet's earnings report,Markets Insider Automation,/news/stocks/insulet-stock-price-quarter-earnings-preview-q2-1027416627,positive,0.918659508228302
25,10/30/2018 3:03:28 PM,Insulet is about to announce earnings — here's what Wall Street expects,Markets Insider Automation,/news/stocks/insulet-q3-earnings-preview-1027671504,positive,0.9362448453903198
26,2/23/2019 3:01:20 PM,Here's what to expect from Insulet's earnings report,Markets Insider Automation,/news/stocks/insulet-q4-earnings-preview-1027976919,positive,0.9325034618377686
27,4/30/2019 3:02:46 PM,Here's what to expect from Insulet's earnings,Markets Insider Automation,/news/stocks/insulet-stock-q1-earnings-preview-1028153782,positive,0.9397184252738953
28,8/3/2019 3:01:30 PM,Insulet is about to announce earnings — here's what Wall Street expects,Markets Insider Automation,/news/stocks/insulet-stock-quarter-earnings-preview-q2-1028413583,positive,0.9362448453903198
29,8/6/2019 8:36:23 AM,"ALNY To Face FDA In Feb., PODD Ups Outlook Again, Catalysts Galore For XLRN ",RTTNews,/news/stocks/alny-to-face-fda-in-feb-podd-ups-outlook-again-catalysts-galore-for-xlrn-1028420401,negative,0.8857188820838928
30,8/6/2019 1:57:01 PM,"Interesting Stocks To Watch On Aug. 6 (TCMD, PODD, ATSG, STE) ",RTTNews,/news/stocks/interesting-stocks-to-watch-on-aug-6-tcmd-podd-atsg-ste-1028421419,positive,0.9263862371444702
31,8/23/2019 2:41:52 PM,"Insulet Corp - Up, Up And Away ",RTTNews,/news/stocks/insulet-corp-up-up-and-away-1028469513,negative,0.5216699242591858
32,11/12/2019 11:36:42 AM,"Healthcare Stocks That Hit New Highs (DXCM, ZLAB, PODD) ",RTTNews,/news/stocks/healthcare-stocks-that-hit-new-highs-dxcm-zlab-podd-1028679761,negative,0.7549057006835938
33,2/13/2020 3:04:14 PM,Insulet issues corrective action for Omnipod DASH PDM,Seeking Alpha,https://seekingalpha.com/news/3541773-insulet-issues-corrective-action-for-omnipod-dash-pdm?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8344293236732483
34,2/24/2020 3:01:36 PM,Insulet earnings: here's what to expect,Markets Insider Automation,/news/stocks/insulet-quarter-earnings-preview-q4-1028931576,positive,0.9346299171447754
35,2/25/2020 9:03:42 PM,"Insulet EPS misses by $0.03, beats on revenue",Seeking Alpha,https://seekingalpha.com/news/3545448-insulet-eps-misses-0_03-beats-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.43494173884391785
36,2/26/2020 2:17:31 PM,"TOL, SDC among premarket losers",Seeking Alpha,https://seekingalpha.com/news/3545827-tol-sdc-among-premarket-losers?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8936212658882141
37,3/2/2020 5:07:41 PM,Stock Alert: Insulet Drops 4% ,RTTNews,/news/stocks/stock-alert-insulet-drops-4-1028956054,neutral,0.9598148465156555
38,3/5/2020 12:37:07 PM,New sell-side coverage - healthcare,Seeking Alpha,https://seekingalpha.com/news/3548949-new-sell-side-coverage-healthcare?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8478836417198181
39,3/31/2020 11:18:15 AM,Mizuho sees 86% upside in Sarepta in premarket analyst action,Seeking Alpha,https://seekingalpha.com/news/3556675-mizuho-sees-86-upside-in-sarepta-in-premarket-analyst-action?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9384837746620178
40,4/24/2020 12:02:23 PM,Citi cuts view on Illumina in premarket analyst action,Seeking Alpha,https://seekingalpha.com/news/3564130-citi-cuts-view-on-illumina-in-premarket-analyst-action?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7593044638633728
41,5/7/2020 3:02:03 PM,Insulet earnings: here's what Wall Street expects,Markets Insider Automation,/news/stocks/insulet-stock-price-q1-earnings-preview-1029177311,positive,0.9279787540435791
42,5/13/2020 9:48:32 AM,Insulet pricesf $500M equity offering,Seeking Alpha,https://seekingalpha.com/news/3573747-insulet-pricesf-500m-equity-offering?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9131233096122742
43,6/13/2020 2:58:41 PM,Medtronic next-gen closed-loop insulin system successful in U.S. trial,Seeking Alpha,https://seekingalpha.com/news/3582830-medtronic-next-gen-closed-loop-insulin-system-successful-in-u-s-trial?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9340391159057617
44,8/5/2020 3:04:13 PM,What Wall Street expects from Insulet's earnings,Markets Insider Automation,/news/stocks/insulet-stock-quarter-earnings-preview-q2-1029472888,positive,0.932806670665741
45,10/21/2020 10:40:55 AM,Diversify Into Timely Telemedicine Stocks with the EDOC ETF,InvestorPlace,/news/stocks/diversify-into-timely-telemedicine-stocks-with-the-edoc-etf-1029704232,positive,0.7395332455635071
46,10/23/2020 9:23:21 PM,"Baird expecting earnings upside in diabetes names, with one top idea",Seeking Alpha,https://seekingalpha.com/news/3625475-baird-expecting-earnings-upside-in-diabetes-names-one-top-idea?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7648540735244751
47,11/3/2020 5:47:37 PM,Insulet Q3 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3630565-insulet-q3-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8746522665023804
48,11/3/2020 10:35:22 PM,Notable earnings after Wednesday's close,Seeking Alpha,https://seekingalpha.com/news/3630529-notable-earnings-after-wednesdays-close?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8919203281402588
49,11/4/2020 9:09:43 PM,"Insulet EPS beats by $0.10, beats on revenue",Seeking Alpha,https://seekingalpha.com/news/3631472-insulet-eps-beats-0_10-beats-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7323614954948425
50,12/27/2020 4:12:23 AM,"With fundamentals intact, MedTech to outperform in 2021 as vaccines drive recovery",Seeking Alpha,https://seekingalpha.com/news/3647430-fundamentals-intact-medtech-to-outperform-in-2021-vaccines-drive-recovery?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9447756409645081
51,1/14/2021 1:56:59 PM,"The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates",Benzinga,/news/stocks/the-daily-biotech-pulse-alexion-pauses-covid-19-study-nantkwest-readout-organogenesis-jumps-on-guidance-trial-updates-1029968277,positive,0.9080525040626526
52,1/15/2021 1:32:12 PM,"The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges",Benzinga,/news/stocks/the-daily-biotech-pulse-dbv-s-positive-fda-feedback-pfizer-s-cancer-drug-gets-label-expansion-applied-dna-covid-testing-volume-surges-1029972538,negative,0.9414128661155701
53,1/18/2021 12:20:51 PM,Insulet Launches Easy-to-use Insulin Delivery System In Canada - Quick Facts ,RTTNews,/news/stocks/insulet-launches-easy-to-use-insulin-delivery-system-in-canada-quick-facts-1029977223,positive,0.6716552972793579
54,1/19/2021 7:50:14 PM,Insulet's insulin management system launched in Canada,Seeking Alpha,https://seekingalpha.com/news/3652398-insulets-insulin-management-system-launched-in-canada?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.793018102645874
55,1/20/2021 1:32:35 PM,"The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study",Benzinga,/news/stocks/the-daily-biotech-pulse-fda-greenlights-merck-s-heart-failure-drug-histogen-hit-with-clinical-hold-aptorum-gets-nod-for-commencing-human-study-1029985849,positive,0.48656928539276123
56,1/21/2021 2:05:24 PM,"The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping",Benzinga,/news/stocks/the-daily-biotech-pulse-addex-jumps-on-positive-data-for-out-licensed-drug-covid-19-vaccine-developer-inovio-announces-150m-follow-on-offering-boston-scientific-goes-shopping-1029990203,negative,0.7720292210578918
57,1/29/2021 4:04:37 PM,"Benzinga's Top Ratings Upgrades, Downgrades For January 29, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-january-29-2021-1030020364,neutral,0.6345635652542114
58,2/20/2021 3:36:28 PM,"The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings",Benzinga,/news/stocks/the-week-ahead-in-biotech-j-j-vaccine-adcom-meeting-sarepta-fda-decision-and-plenty-of-earnings-1030104010,positive,0.8801164627075195
59,2/21/2021 3:01:30 PM,Insulet earnings: here's what to expect,Markets Insider Automation,/news/stocks/insulet-stock-price-quarter-earnings-preview-q4-1030104771,positive,0.9346299171447754
60,2/22/2021 10:35:09 PM,Notable earnings after Tuesday's close,Seeking Alpha,https://seekingalpha.com/news/3664433-notable-earnings-after-tuesdays-close?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8953564763069153
61,2/22/2021 10:35:43 PM,Insulet Q4 2020 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3664447-insulet-q4-2020-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8775001764297485
62,2/23/2021 1:25:48 PM,"The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts",Benzinga,/news/stocks/the-daily-biotech-pulse-aridis-to-study-antibody-cocktail-for-coronavirus-variants-revance-protalix-data-readouts-1030112231,positive,0.9188618659973145
63,3/19/2021 12:25:44 PM,Idera suffers downgrades after trial setback; Kiniksa target upped on FDA win; and more in today’s analyst calls,Seeking Alpha,https://seekingalpha.com/news/3674376-idera-suffers-downgrades-after-trial-setback-kiniksa-target-upped?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6281257271766663
64,3/19/2021 3:22:42 PM,Insulet upgraded at Canaccord Genuity on recent weakness,Seeking Alpha,https://seekingalpha.com/news/3674455-insulet-upgraded-at-canaccord-genuity-on-recent-weakness?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5118234753608704
65,3/19/2021 7:30:46 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3674473-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8980498313903809
66,3/22/2021 10:10:20 AM,Insulet’s insulin delivery system shows promise in pivotal trial,Seeking Alpha,https://seekingalpha.com/news/3674641-insulets-insulin-delivery-system-shows-promise-in-pivotal-trial?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.929502546787262
67,4/1/2021 12:29:29 PM,"Gilead’s upcoming catalysts to close valuation gap; Insulet upgraded at SVB Leerink, and more in today’s analyst action",Seeking Alpha,https://seekingalpha.com/news/3678503-gileads-to-close-valuation-gap-insulet-upgraded-in-todays-analyst-action?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7071816325187683
68,4/1/2021 2:42:08 PM,10 Biggest Price Target Changes For Thursday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-thursday-1030268939,positive,0.7969076037406921
69,4/1/2021 4:02:52 PM,"Benzinga's Top Ratings Upgrades, Downgrades For April 1, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-april-1-2021-1030269442,positive,0.5060772895812988
70,4/19/2021 4:54:00 PM,Insulet Corporation -- Moody's assigns B2 CFR to Insulet; Ba3 sr. secured,Moodys,/news/bonds/insulet-corporation-moody-s-assigns-b2-cfr-to-insulet-ba3-sr-secured-1030318565,negative,0.6098163723945618
71,4/19/2021 5:09:00 PM,Insulet Corporation -- Moody's assigns B2 CFR to Insulet; Ba3 sr. secured,Moodys,/news/bonds/insulet-corporation-moody-s-assigns-b2-cfr-to-insulet-ba3-sr-secured-1030318647,negative,0.6098163723945618
72,4/29/2021 2:15:50 PM,"The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx",Benzinga,/news/stocks/the-daily-biotech-pulse-clinical-setback-for-adverum-galera-posts-data-readout-moderna-to-invest-in-vaccine-manufacturing-decision-day-for-ardelyx-1030364740,positive,0.7717582583427429
73,4/29/2021 9:12:45 PM,Insulet prices two senior secured credit facilities,Seeking Alpha,https://seekingalpha.com/news/3688374-insulet-prices-two-senior-secured-credit-facilities?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9317339062690735
74,4/30/2021 1:31:19 PM,"The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs",Benzinga,/news/stocks/the-daily-biotech-pulse-hyperphosphatemia-drug-regulatory-review-extended-phathom-pharma-data-readout-2-ipos-1030369950,positive,0.896331250667572
75,5/1/2021 7:19:25 PM,"Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge",Benzinga,/news/stocks/week-ahead-in-biotech-may-2-8-chemocentryx-adcom-ophthalmology-conference-presentations-earnings-deluge-1030373608,positive,0.8418352007865906
76,5/5/2021 9:35:59 PM,Insulet Q1 2021 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3691209-insulet-q1-2021-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8682017922401428
77,5/6/2021 1:49:39 PM,"The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom",Benzinga,/news/stocks/the-daily-biotech-pulse-merck-s-keytruda-snags-another-fda-approval-moderna-slips-on-revenue-miss-chemocentryx-adcom-1030395950,neutral,0.9611167907714844
78,5/18/2021 4:39:32 PM,"Tech focused, Lone Pine Capital acquires new position in Workday, exits Docusign, expands stake in Snowflake",Seeking Alpha,https://seekingalpha.com/news/3697794-tech-focused-lone-pine-capital-acquires-new-position-in-workday-exits-docusign-expands-stake-in-snowflake?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8020023703575134
79,5/25/2021 4:02:44 PM,"Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-may-25-2021-1030463045,neutral,0.5758827924728394
80,5/25/2021 6:07:34 PM,"Barclays sees ""renaissance"" in medical device industry",Seeking Alpha,https://seekingalpha.com/news/3699979-barclays-sees-renaissance-in-medical-device-industry?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7192384600639343
81,7/15/2021 4:13:26 PM,FDA devices head says progress being made on diabetes devices backlog,Seeking Alpha,https://seekingalpha.com/news/3715640-fda-devices-head-says-progress-being-made-on-diabetes-devices-backlog?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8434410095214844
82,8/1/2021 2:03:36 PM,DexCom price target raised at Baird; upcoming catalysts cited,Seeking Alpha,https://seekingalpha.com/news/3722745-dexcom-price-target-raised-at-baird-upcoming-catalysts-cited?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.49969685077667236
83,8/3/2021 3:02:13 PM,Insulet is about to announce earnings — here's what Wall Street expects,Markets Insider Automation,/news/stocks/insulet-stock-q2-earnings-preview-1030683340,positive,0.9362448453903198
84,8/4/2021 9:35:49 PM,Notable earnings after Thursday's close,Seeking Alpha,https://seekingalpha.com/news/3724969-notable-earnings-after-thursdays-close?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8900269269943237
85,9/8/2021 1:32:08 PM,"The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod",Benzinga,/news/stocks/the-daily-biotech-pulse-macrogenics-clinical-trial-disappointment-sanofi-to-buy-kadmon-alector-loses-2-key-executives-adma-s-fda-nod-1030786678,positive,0.5691104531288147
86,9/9/2021 2:17:07 PM,"The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization",Benzinga,/news/stocks/the-daily-biotech-pulse-proqr-lilly-r-d-partnership-sanofi-s-pemphigus-trial-disappointment-humanigen-s-covid-19-drug-denied-emergency-use-authorization-1030789942,positive,0.9088907241821289
87,9/30/2021 1:52:50 PM,Insulet's Omnipod 5 Study Data Shows Improvements In Glycemic Control With One Year Of Use ,RTTNews,/news/stocks/insulet-s-omnipod-5-study-data-shows-improvements-in-glycemic-control-with-one-year-of-use-1030833765,negative,0.9480075836181641
88,10/31/2021 7:23:54 PM,"The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline",Benzinga,/news/stocks/the-week-ahead-in-biotech-oct-31-nov-6-earnings-pick-up-pace-eton-awaits-seizure-drug-approval-kidney-conference-more-ipos-in-the-pipeline-1030917750,negative,0.939061164855957
89,11/3/2021 3:01:13 PM,Insulet earnings preview: what Wall Street is expecting,Markets Insider Automation,/news/stocks/insulet-stock-q3-earnings-preview-1030932498,positive,0.9168083071708679
90,11/4/2021 1:14:49 PM,"The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-merck-s-oral-covid-19-pill-authorized-in-uk-novartis-cashes-out-of-roche-chimerix-plunges-on-data-evotec-ipo-1030937079,neutral,0.8839086890220642
91,11/5/2021 3:05:06 PM,10 Biggest Price Target Changes For Friday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-friday-1030942944,positive,0.7916322350502014
92,11/8/2021 1:24:09 PM,10 Biggest Price Target Changes For Monday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-monday-1030948648,positive,0.7998325824737549
93,12/3/2021 6:36:42 PM,Insulet drops 10% as CEO indicates launch of Omnipod insulin product likely delayed,Seeking Alpha,https://seekingalpha.com/news/3777027-insulet-drops-10-as-ceo-indicates-launch-of-omnipod-insulin-product-likely-delayed?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8865537643432617
94,12/15/2021 2:35:00 PM,"Diabetes tech market still has a clear favorite, Baird says",Seeking Alpha,https://seekingalpha.com/news/3780179-diabetes-tech-market-still-has-a-clear-favorite-baird-says?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5169559717178345
95,1/19/2022 5:02:24 PM,Tandem Diabetes on the rise after Wells Fargo upgraded on sales prospects,Seeking Alpha,https://seekingalpha.com/news/3789270-tandem-diabetes-on-the-rise-after-wells-fargo-upgraded-on-sales-prospects?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7899617552757263
96,1/28/2022 11:32:16 AM,FDA clears Insulet's Omnipod 5 automated insulin delivery system,Seeking Alpha,https://seekingalpha.com/news/3792930-fda-clears-insulets-omnipod-5-automated-insulin-delivery-system?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5876595973968506
97,1/28/2022 12:51:26 PM,Insulet Gets FDA Clearance For Omnipod 5 Tubeless Automated Insulin Delivery System ,RTTNews,/news/stocks/insulet-gets-fda-clearance-for-omnipod-5-tubeless-automated-insulin-delivery-system-1031138937,negative,0.8938462138175964
98,1/28/2022 3:02:11 PM,"Inspira, Provention lead healthcare gainers; Aridis, NeuroBo among losers",Seeking Alpha,https://seekingalpha.com/news/3793105-inspira-provention-lead-healthcare-gainers-aridis-neurobo-among-losers?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.766346275806427
99,1/28/2022 5:45:17 PM,"CINR, CUE and PCYG among mid-day movers",Seeking Alpha,https://seekingalpha.com/news/3793180-cinr-cue-and-pcyg-among-mid-day-movers?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9000408053398132
100,1/28/2022 6:07:02 PM,33 Stocks Moving In Friday's Mid-Day Session,Benzinga,/news/stocks/33-stocks-moving-in-friday-s-mid-day-session-1031140025,neutral,0.6656431555747986
101,1/28/2022 6:11:42 PM,Mid-Day Market Update: US Stocks Turn Positive; Nasdaq Surges 2%,Benzinga,/news/stocks/mid-day-market-update-us-stocks-turn-positive-nasdaq-surges-2-1031140024,negative,0.9283427596092224
102,1/31/2022 11:03:54 AM,52 Biggest Movers From Friday,Benzinga,/news/stocks/52-biggest-movers-from-friday-1031143541,positive,0.8689245581626892
103,1/31/2022 4:26:50 PM,Expert Ratings For Insulet,Benzinga,/news/stocks/expert-ratings-for-insulet-1031144941,positive,0.8909010291099548
104,1/31/2022 4:28:37 PM,"Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-january-31-2022-1031144938,neutral,0.5268808007240295
105,1/31/2022 4:46:39 PM,Insulet upgraded at Oppenheimer despite recent surge on FDA approval for Omnipod 5,Seeking Alpha,https://seekingalpha.com/news/3793599-insulet-upgraded-at-oppenheimer-despite-recent-surge-on-fda-approval-for-omnipod-5?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9129464030265808
106,2/2/2022 4:05:51 PM,"Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-february-2-2022-1031154681,neutral,0.49187353253364563
107,2/3/2022 4:04:23 PM,"Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-february-3-2022-1031159425,positive,0.48700419068336487
108,2/20/2022 2:06:46 PM,"The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow",Benzinga,/news/stocks/the-week-ahead-in-biotech-feb-20-26-reata-awaits-fda-decision-bausch-health-moderna-lead-earnings-news-flow-1031210514,positive,0.9087624549865723
109,2/22/2022 10:35:27 PM,Insulet Q4 2021 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3802544-insulet-q4-2021-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8660129904747009
110,2/22/2022 10:35:57 PM,Notable earnings after Wednesday's close,Seeking Alpha,https://seekingalpha.com/news/3802538-notable-earnings-after-wednesdays-close?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8919203281402588
111,2/23/2022 2:01:22 PM,"The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development",Benzinga,/news/stocks/the-daily-biotech-pulse-kodiak-sinks-on-adverse-study-outcome-marinus-flags-delay-in-clinical-trial-mainz-biomed-gains-on-positive-regulatory-development-1031220931,neutral,0.6420804262161255
112,2/23/2022 9:04:13 PM,"Insulet GAAP EPS of $0.42 beats by $0.11, revenue of $307.7M beats by $7.13M",Seeking Alpha,https://seekingalpha.com/news/3804527-insulet-gaap-eps-of-0_42-beats-0_11-revenue-of-307_7m-beats-7_13m?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7323899269104004
113,5/4/2022 9:35:55 PM,Notable earnings after Thursday's close,Seeking Alpha,https://seekingalpha.com/news/3832050-notable-earnings-after-thursdays-close?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8900269269943237
114,5/5/2022 3:21:17 PM,Tandem drags rival insulin pump makers as analysts cut targets after 1Q earnings,Seeking Alpha,https://seekingalpha.com/news/3833468-tndm-stock-drags-rivals-as-analysts-cut-targets-after-1q-earnings-?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9569442868232727
115,5/5/2022 8:25:31 PM,"Insulet GAAP EPS of $0.40 beats by $0.17, revenue of $295.4M beats by $7.41M",Seeking Alpha,https://seekingalpha.com/news/3833734-insulet-gaap-eps-of-0_40-beats-0_17-revenue-of-295_4m-beats-7_41m?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7096258997917175
116,5/5/2022 8:26:30 PM,Insulet CEO Shacey Petrovic to step down,Seeking Alpha,https://seekingalpha.com/news/3833740-insulet-ceo-shacey-petrovic-to-step-down?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6310065984725952
117,5/6/2022 5:56:21 PM,Insulet -11% after Wells Fargo lowers PT after Q1 earnings,Seeking Alpha,https://seekingalpha.com/news/3834478-insulet-11-after-wells-fargo-lowers-pt-after-q1-earnings?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9067360758781433
118,5/6/2022 7:02:31 PM,Expert Ratings for Insulet,Benzinga,/news/stocks/expert-ratings-for-insulet-1031431648,positive,0.8909010291099548
119,5/17/2022 2:23:51 PM,10 Biggest Price Target Changes For Tuesday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-tuesday-1031468322,positive,0.8152946829795837
120,5/17/2022 6:00:40 PM,Citigroup Maintains Buy Rating for Insulet: Here's What You Need To Know,Benzinga,/news/stocks/citigroup-maintains-buy-rating-for-insulet-here-s-what-you-need-to-know-1031469405,positive,0.9359748363494873
121,5/24/2022 1:03:16 AM,Insulet jumps on report Dexcom in talks to acquire,Seeking Alpha,https://seekingalpha.com/news/3842032-insulet-jumps-on-report-dexcom-in-talks-to-acquire?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5540673732757568
122,5/24/2022 11:29:47 AM,Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday,InvestorPlace,/news/stocks/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-may-24-1031484506,neutral,0.5084244012832642
123,5/24/2022 12:36:20 PM,"CANG,CELZ and BTTX among pre market gainers",Seeking Alpha,https://seekingalpha.com/news/3842152-cangcelz-and-bttx-among-pre-market-gainers?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9042837619781494
124,5/24/2022 1:15:44 PM,"Pre-market Movers: BBAI, SNAP, CANG, BGXX, NLS… ",RTTNews,/news/stocks/pre-market-movers-bbai-snap-cang-bgxx-nls-1031484468,positive,0.9514930248260498
125,5/24/2022 2:02:18 PM,"Allarity, Better Therapeutics top healthcare gainers; INmune Bio, Liquidia lead losers' pack",Seeking Alpha,https://seekingalpha.com/news/3842251-allarity-better-therapeutics-top-healthcare-gainers-inmune-bio-liquidia-lead-losers-pack?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.776110053062439
126,5/24/2022 2:52:06 PM,PODD Stock Pops 7% as DexCom Considers Insulet Corporation Acquisition,InvestorPlace,/news/stocks/podd-stock-pops-7-as-dexcom-considers-insulet-corporation-acquisition-1031485620,negative,0.5653537511825562
127,5/31/2022 12:46:04 PM,DexCom gains after rejecting market rumors on M&A deal; Insulet drops,Seeking Alpha,https://seekingalpha.com/news/3843903-dxcm-stock-gains-after-rejecting-market-rumors-on-ma-deal-podd-stock-drops?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8544209003448486
128,5/31/2022 2:03:54 PM,"TherapeuticsMD, MoonLake top healthcare gainers; Outlook, Elevation Oncology lead losers' pack",Seeking Alpha,https://seekingalpha.com/news/3843986-therapeuticsmd-moonlake-top-healthcare-gainers-outlook-elevation-oncology-lead-losers-pack?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8514291644096375
129,6/7/2022 7:11:24 PM,4 Analysts Have This to Say About Insulet,Benzinga,/news/stocks/4-analysts-have-this-to-say-about-insulet-1031514347,positive,0.9265811443328857
130,6/23/2022 11:00:24 AM,7 Stocks to Buy That Could Make You a Millionaire,InvestorPlace,/news/stocks/7-stocks-to-buy-that-could-make-you-a-millionaire-2-1031545713,positive,0.869046151638031
131,6/24/2022 5:26:45 PM,5 Analysts Have This to Say About Insulet,Benzinga,/news/stocks/5-analysts-have-this-to-say-about-insulet-1031549197,positive,0.9281656742095947
132,7/11/2022 3:25:44 PM,Insulet to pay $20M to Roche in patent settlement,Seeking Alpha,https://seekingalpha.com/news/3855728-insulet-to-pay-20m-to-settle-patent-lawsuit?utm_source=businessinsider&utm_medium=referral,positive,0.8960946202278137
133,7/11/2022 5:53:47 PM,"Benzinga's Top Ratings Upgrades, Downgrades For July 11, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-july-11-2022-1031578887,positive,0.5117996335029602
134,8/3/2022 3:01:13 PM,Insulet is about to announce its earnings — here's what Wall Street expects,Markets Insider Automation,/news/stocks/insulet-stock-price-q2-earnings-preview-1031645407,positive,0.9349967837333679
135,8/4/2022 8:02:56 PM,"Insulet GAAP EPS of -$0.50 misses by $0.73, revenue of $299.4M beats by $8.53M",Seeking Alpha,https://seekingalpha.com/news/3867473-insulet-gaap-eps-of-0_50-misses-0_73-revenue-of-299_4m-beats-8_53m?utm_source=businessinsider&utm_medium=referral,positive,0.572127103805542
136,8/5/2022 2:42:18 PM,"Insulet Posts Q2 Revenue Beat, Lifts FY22 Guidance",Benzinga,/news/stocks/insulet-posts-q2-revenue-beat-lifts-fy22-guidance-1031655716,negative,0.8609001040458679
137,8/5/2022 8:08:36 PM,What 8 Analyst Ratings Have To Say About Insulet,Benzinga,/news/stocks/what-8-analyst-ratings-have-to-say-about-insulet-1031656438,positive,0.9452075958251953
138,8/9/2022 12:06:58 PM,Tandem draws double downgrade at Wells Fargo on competition headwinds,Seeking Alpha,https://seekingalpha.com/news/3869680-tndm-stock-draws-double-downgrade-at-wells-fargo?utm_source=businessinsider&utm_medium=referral,neutral,0.9514756798744202
139,8/22/2022 10:35:26 AM,Insulet wins FDA nod to use insulin delivery system in 2 – 5-year-olds,Seeking Alpha,https://seekingalpha.com/news/3875294-podd-stock-on-watch-on-fda-nod-for-omnipod-5-in-young-children?utm_source=businessinsider&utm_medium=referral,negative,0.8758726119995117
140,8/22/2022 12:27:15 PM,Insulet: Automated Insulin Delivery System Omnipod 5 Gets FDA Clearance ,RTTNews,/news/stocks/insulet-automated-insulin-delivery-system-omnipod-5-gets-fda-clearance-1031697501,negative,0.5424777269363403
141,8/22/2022 2:28:02 PM,"Benzinga Before The Bell: Apple Employees Resist Calls For Return-To-Office, Tesla About To Hike FSD Prices Again, MGM China Injects $594M Into Macau Unit And Other Top Financial Stories Monday,...",Benzinga,/news/stocks/benzinga-before-the-bell-apple-employees-resist-calls-for-return-to-office-tesla-about-to-hike-fsd-prices-again-mgm-china-injects-594m-into-macau-unit-and-other-top-financial-stories-monday-august-22-1031697874,positive,0.4117203652858734
142,8/23/2022 1:10:36 AM,Recap Of Monday's Biotech Catalysts - End Of the Day Summary,Benzinga,/news/stocks/recap-of-monday-s-biotech-catalysts---end-of-the-day-summary-1031699141,positive,0.9351576566696167
143,9/20/2022 1:52:07 PM,Insulet automated insulin delivery system Omnipod 5 gets CE mark,Seeking Alpha,https://seekingalpha.com/news/3884376-insulet-automated-insulin-delivery-system-omnipod-5-gets-ce-mark?utm_source=businessinsider&utm_medium=referral,positive,0.806731104850769
144,10/12/2022 3:24:55 PM,Analyst Ratings for Insulet,Benzinga,/news/stocks/analyst-ratings-for-insulet-1031799841,positive,0.9261480569839478
145,10/12/2022 4:02:53 PM,"Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-october-12-2022-1031799955,positive,0.5273875594139099
146,10/18/2022 4:21:58 PM,"Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-october-18-2022-1031813984,positive,0.4930572509765625
147,10/31/2022 12:12:46 PM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Insulet (PODD), Resmed (RMD) and Merck & Company (MRK)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-insulet-podd-resmed-rmd-and-merck-company-mrk-1031853390,neutral,0.8243153691291809
148,11/2/2022 3:01:13 PM,Here's what to expect from Insulet's earnings,Markets Insider Automation,/news/stocks/insulet-q3-quarterly-earnings-preview-1031864489,positive,0.9397184252738953
149,11/3/2022 8:32:14 PM,"Insulet Non-GAAP EPS of $0.45 beats by $0.31, revenue of $340.8M beats by $29.58M",Seeking Alpha,https://seekingalpha.com/news/3901423-insulet-non-gaap-eps-of-0_45-beats-0_31-revenue-of-340_8m-beats-29_58m?utm_source=businessinsider&utm_medium=referral,positive,0.688907265663147
150,11/4/2022 4:10:19 AM,Analysts Offer Insights on Healthcare Companies: Insulet (PODD) and Corvus Pharmaceuticals (CRVS),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-insulet-podd-and-corvus-pharmaceuticals-crvs-1031873161,positive,0.9002442359924316
151,11/4/2022 12:16:35 PM,"US Market Poised To End Week On High Note: Nasdaq, S&P 500 Futures Rally As Investors' Attention Moves Away From Fed Rate Hike To Friday's Jobs Report",Benzinga,/news/stocks/us-market-poised-to-end-week-on-high-note-nasdaq-s-p-500-futures-rally-as-investors-attention-moves-away-from-fed-rate-hike-to-friday-s-jobs-report-1031875432,negative,0.7871361374855042
152,11/4/2022 1:35:09 PM,Why Starbucks Shares Are Trading Higher; Here Are 43 Stocks Moving Premarket,Benzinga,/news/stocks/why-starbucks-shares-are-trading-higher-here-are-43-stocks-moving-premarket-1031875809,positive,0.8911372423171997
153,11/4/2022 2:02:09 PM,"BioAtla, TransMedics top healthcare gainers; Pulmonx, NeuroBo lead losers' pack",Seeking Alpha,https://seekingalpha.com/news/3901958-bioatla-transmedics-top-healthcare-gainers-pulmonx-neurobo-lead-losers-pack?utm_source=businessinsider&utm_medium=referral,negative,0.8244131803512573
154,11/4/2022 2:32:06 PM,What 5 Analyst Ratings Have To Say About Insulet,Benzinga,/news/stocks/what-5-analyst-ratings-have-to-say-about-insulet-1031876003,positive,0.9430116415023804
155,11/4/2022 3:41:38 PM,"Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-november-4-2022-1031876331,neutral,0.4883694648742676
156,11/4/2022 4:26:05 PM,"Block, MasTec, Universal Display And Some Other Big Stocks Moving Higher On Friday",Benzinga,/news/stocks/block-mastec-universal-display-and-some-other-big-stocks-moving-higher-on-friday-1031876480,negative,0.9190420508384705
157,11/4/2022 4:39:14 PM,"Insulet stock soars 17% on Q3 beat, raised FY22 revenue outlook",Seeking Alpha,https://seekingalpha.com/news/3902103-insulet-stock-soars-on-q3-beat-raised-fy22-revenue-outlook?utm_source=businessinsider&utm_medium=referral,negative,0.9366616606712341
158,11/4/2022 4:41:15 PM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Insulet (PODD), Veracyte (VCYT) and Moderna (MRNA)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-insulet-podd-veracyte-vcyt-and-moderna-mrna-1031876731,neutral,0.7265635132789612
159,11/4/2022 5:54:47 PM,Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session,Benzinga,/news/stocks/why-yelp-shares-are-trading-lower-by-15-here-are-86-stocks-moving-in-friday-s-mid-day-session-1031876746,neutral,0.7951362729072571
160,11/7/2022 9:07:41 AM,Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday,Benzinga,/news/stocks/why-mediaalpha-shares-jumped-around-30-here-are-112-biggest-movers-from-friday-1031880342,positive,0.9270442128181458
161,11/15/2022 1:25:18 PM,Tandem upgraded at Wells Fargo as valuation and consensus reset,Seeking Alpha,https://seekingalpha.com/news/3907823-tndm-stock-upgraded-at-wells-fargo-as-valuation-and-consensus-reset?utm_source=businessinsider&utm_medium=referral,positive,0.7496330738067627
162,11/16/2022 6:26:19 AM,Insulet Issues Medical Device Correction For Omnipod 5 Controller ,RTTNews,/news/stocks/insulet-issues-medical-device-correction-for-omnipod-5-controller-1031916945,positive,0.8626736402511597
163,12/14/2022 9:52:42 PM,Insulet CEO Charles Alpuche  to retire,Seeking Alpha,https://seekingalpha.com/news/3917267-insulet-ceo-charles-alpuche-to-retire?utm_source=businessinsider&utm_medium=referral,positive,0.8882347345352173
164,1/6/2023 4:25:50 PM,Insulet (PODD) Gets a Hold from Morgan Stanley,TipRanks,/news/stocks/insulet-podd-gets-a-hold-from-morgan-stanley-1032004670,positive,0.7967308163642883
165,1/23/2023 6:47:11 PM,Insulet hit by data breach affecting 29K insulin pump users,Seeking Alpha,https://seekingalpha.com/news/3926836-insulet-hit-by-data-breach-affecting-29k-insulin-pump-users?utm_source=businessinsider&utm_medium=referral,neutral,0.9646384716033936
166,1/26/2023 3:15:55 PM,DexCom favored as Wolfe launches coverage on diabetes device makers,Seeking Alpha,https://seekingalpha.com/news/3928458-dexcom-favored-wolfe-launches-coverage-diabetes-device-makers?utm_source=businessinsider&utm_medium=referral,positive,0.5225849747657776
167,1/26/2023 4:00:36 PM,"Benzinga's Top Ratings Upgrades, Downgrades For January 26, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-january-26-2023-1032044192,neutral,0.5691909790039062
168,2/9/2023 8:37:16 PM,The 7 Best Tech Stocks to Buy for February 2023,InvestorPlace,/news/stocks/the-7-best-tech-stocks-to-buy-for-february-2023-1032084240,positive,0.9065125584602356
169,2/13/2023 11:16:58 AM,Insulet buys insulin pump patents from Bigfoot Biomedical for $25M,Seeking Alpha,https://seekingalpha.com/news/3935096-insulet-buys-insulin-pump-patents-from-bigfoot-biomedical-for-25m?utm_source=businessinsider&utm_medium=referral,positive,0.8811468482017517
170,2/14/2023 11:25:12 AM,Insulet acquires assets of Automated Glucose Control for $25M,Seeking Alpha,https://seekingalpha.com/news/3935607-insulet-acquires-assets-of-automated-glucose-control-for-25m?utm_source=businessinsider&utm_medium=referral,positive,0.8832276463508606
171,2/22/2023 3:01:13 PM,Insulet is about to announce its earnings — here's what to expect,Markets Insider Automation,/news/stocks/insulet-q4-quarterly-earnings-preview-stock-1032115739,positive,0.9399052262306213
172,2/22/2023 10:35:34 PM,Insulet Q4 2022 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3939296-insulet-q4-2022-earnings-preview?utm_source=businessinsider&utm_medium=referral,positive,0.9224150776863098
173,2/23/2023 9:05:01 PM,"Insulet Non-GAAP EPS of $0.55 beats by $0.36, revenue of $369.7M beats by $37.97M",Seeking Alpha,https://seekingalpha.com/news/3940182-insulet-non-gaap-eps-of-0_55-beats-0_36-revenue-of-369_7m-beats-37_97m?utm_source=businessinsider&utm_medium=referral,positive,0.7197145223617554
174,2/24/2023 12:01:54 PM,"Analysts Conflicted on These Healthcare Names: Graphite Bio (GRPH), Insulet (PODD) and Guardant Health (GH)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-graphite-bio-grph-insulet-podd-and-guardant-health-gh-1032123319,neutral,0.7540298700332642
175,2/24/2023 2:40:16 PM,Analysts Offer Insights on Healthcare Companies: Insulet (PODD) and Lemaitre Vascular (LMAT),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-insulet-podd-and-lemaitre-vascular-lmat-1032123859,positive,0.8946900963783264
176,2/24/2023 10:01:27 PM,Analyst Expectations for Insulet's Future,Benzinga,/news/stocks/analyst-expectations-for-insulet-s-future-1032124671,negative,0.833166778087616
177,3/6/2023 4:32:32 PM,DexCom slips as Abbott wins FDA nod for CGM integration,Seeking Alpha,https://seekingalpha.com/news/3944516-dexcom-slips-abbott-wins-fda-nod-for-cgm-integration?utm_source=businessinsider&utm_medium=referral,neutral,0.838771641254425
178,3/10/2023 11:33:40 PM,Insulet jumps 8% as it moves to S&P 500 to fill SVB hole,Seeking Alpha,https://seekingalpha.com/news/3946634-insulet-jumps-8-as-it-moves-to-sp-500-to-fill-svb-hole?utm_source=businessinsider&utm_medium=referral,negative,0.6750150322914124
179,3/11/2023 12:58:00 AM,Insulet Set to Join S&P 500,PR Newswire,/news/stocks/insulet-set-to-join-s-p-500-1032161017,positive,0.9378095269203186
180,3/26/2023 4:00:27 PM,Global continuous glucose monitoring market to hit $32B by 2031 – report,Seeking Alpha,https://seekingalpha.com/news/3951266-global-cgm-market-to-hit-32b-by-2031?utm_source=businessinsider&utm_medium=referral,negative,0.7806898951530457
181,3/29/2023 8:31:59 PM,Why did Tandem Diabetes Care stock go down today?,Seeking Alpha,https://seekingalpha.com/news/3952467-why-did-tandem-diabetes-care-stock-go-down-today?utm_source=businessinsider&utm_medium=referral,neutral,0.920922577381134
182,4/14/2023 12:20:08 PM,"Analysts Offer Insights on Healthcare Companies: Insulet (PODD), Pfizer (PFE) and Baudax Bio (BXRX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-insulet-podd-pfizer-pfe-and-baudax-bio-bxrx-1032232740,positive,0.8952935934066772
183,4/17/2023 9:01:20 PM,4 Analysts Have This to Say About Insulet,Benzinga,/news/stocks/4-analysts-have-this-to-say-about-insulet-1032237404,positive,0.9265811443328857
184,4/25/2023 10:23:45 AM,Insulet's wearable insulin device Omnipod GO gets FDA clearance,Seeking Alpha,https://seekingalpha.com/news/3959544-insulets-wearable-insulin-device-omnipod-go-gets-fda-clearance?utm_source=businessinsider&utm_medium=referral,negative,0.6224708557128906
185,5/3/2023 3:01:13 PM,Insulet earnings: here's what Wall Street expects,Markets Insider Automation,/news/stocks/insulet-q1-quarterly-earnings-preview-1032287754,positive,0.9279787540435791
186,5/3/2023 9:35:33 PM,Notable earnings after Thursday's close,Seeking Alpha,https://seekingalpha.com/news/3964494-notable-earnings-after-thursdays-close?utm_source=businessinsider&utm_medium=referral,negative,0.8900269269943237
187,5/3/2023 9:35:39 PM,Insulet Q1 2023 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3964808-insulet-q1-2023-earnings-preview?utm_source=businessinsider&utm_medium=referral,positive,0.9232000112533569
188,5/4/2023 8:03:41 PM,"Insulet Non-GAAP EPS of $0.23 beats by $0.13, revenue of $358.1M beats by $27.89M",Seeking Alpha,https://seekingalpha.com/news/3965931-insulet-non-gaap-eps-of-0_23-beats-0_13-revenue-of-358_1m-beats-27_89m?utm_source=businessinsider&utm_medium=referral,positive,0.7466886639595032
189,5/5/2023 3:01:01 AM,Analysts Conflicted on These Healthcare Names: Insulet (PODD) and Alector (ALEC),TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-insulet-podd-and-alector-alec-1032294705,neutral,0.5340755581855774
190,5/5/2023 11:16:11 AM,Piper Sandler Remains a Buy on Insulet (PODD),TipRanks,/news/stocks/piper-sandler-remains-a-buy-on-insulet-podd-1032297023,positive,0.9468927383422852
191,5/5/2023 4:25:23 PM,Morgan Stanley Keeps Their Hold Rating on Insulet (PODD),TipRanks,/news/stocks/morgan-stanley-keeps-their-hold-rating-on-insulet-podd-1032298274,positive,0.9247866272926331
192,5/8/2023 10:10:13 AM,Analysts Offer Insights on Healthcare Companies: Insulet (PODD) and Twist Bioscience (TWST),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-insulet-podd-and-twist-bioscience-twst-1032301429,positive,0.9062533378601074
193,5/25/2023 3:53:39 PM,"Insulet, Tandem fall as Medtronic to buy insulin pump maker",Seeking Alpha,https://seekingalpha.com/news/3975145-insulet-stock-falls-medtronic-buy-insulin-pump-maker?utm_source=businessinsider&utm_medium=referral,negative,0.4109179377555847
194,5/25/2023 4:55:07 PM,BTIG Sticks to Its Buy Rating for Insulet (PODD),TipRanks,/news/stocks/btig-sticks-to-its-buy-rating-for-insulet-podd-1032352499,positive,0.8046631813049316
195,5/26/2023 2:49:21 PM,Medtronic's EOflow Acquisition Will Not Impact Insulet's Omnipod' Insulin Pump In Near or Medium Term: Analyst,Benzinga,/news/stocks/medtronic-s-eoflow-acquisition-will-not-impact-insulet-s-omnipod-insulin-pump-in-near-or-medium-term-analyst-1032354339,positive,0.9356763362884521
196,5/29/2023 10:39:55 PM,"Insiders Pour Millions Into These 2 Beaten-Down Stocks, Analysts Say They Could Be Ready to Bounce Back — Here’s Why You Should Pay Attention",TipRanks,/news/stocks/insiders-pour-millions-into-these-2-beaten-down-stocks-analysts-say-they-could-be-ready-to-bounce-back-—-here-s-why-you-should-pay-attention-1032356824,positive,0.8916192650794983
197,5/30/2023 8:00:32 PM,Expert Ratings for Insulet,Benzinga,/news/stocks/expert-ratings-for-insulet-1032359085,positive,0.8909010291099548
198,7/3/2023 3:24:56 PM,Goldman Sachs Reveals Winning Portfolio: 'Rule of 10' Unlocks S&P 500's Future Top Performers,Benzinga,/news/stocks/goldman-sachs-reveals-winning-portfolio-rule-of-10-unlocks-s-p-500-s-future-top-performers-1032423564,negative,0.5917136073112488
199,7/4/2023 5:00:00 PM,"Paycom, Chipotle highlight Goldman's Rule of 10 stock screens",Seeking Alpha,https://seekingalpha.com/news/3985021-goldman-sachs-rule-of-10-stock-picks?utm_source=businessinsider&utm_medium=referral,positive,0.913677453994751
200,8/7/2023 3:01:13 PM,Insulet earnings: here's what Wall Street expects,Markets Insider Automation,/news/stocks/insulet-q2-earnings-preview-1032523910,positive,0.9279787540435791
201,8/7/2023 9:35:44 PM,Insulet Q2 2023 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3998385-insulet-q2-2023-earnings-preview?utm_source=businessinsider&utm_medium=referral,positive,0.921360194683075
202,8/8/2023 8:24:55 PM,"Insulet Non-GAAP EPS of $0.38 beats by $0.12, revenue of $396.5M beats by $11.4M",Seeking Alpha,https://seekingalpha.com/news/3999483-insulet-non-gaap-eps-of-0_38-beats-0_12-revenue-of-396_5m-beats-11_4m?utm_source=businessinsider&utm_medium=referral,positive,0.7512186765670776
203,8/9/2023 9:10:21 AM,"Analysts Are Bullish on These Healthcare Stocks: Qiagen (QGEN), Royalty Pharma (RPRX)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-qiagen-qgen-royalty-pharma-rprx-1032533975,positive,0.5646689534187317
204,8/9/2023 10:40:07 AM,"Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN), Qiagen (QGEN) and Insulet (PODD)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-arvinas-holding-company-arvn-qiagen-qgen-and-insulet-podd-1032534265,positive,0.920837938785553
205,8/9/2023 11:25:41 AM,Piper Sandler Sticks to Their Buy Rating for Insulet (PODD),TipRanks,/news/stocks/piper-sandler-sticks-to-their-buy-rating-for-insulet-podd-1032534514,positive,0.8683613538742065
206,8/10/2023 7:30:35 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Iovance Biotherapeutics (IOVA), Insulet (PODD) and Illumina (ILMN)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-iovance-biotherapeutics-iova-insulet-podd-and-illumina-ilmn-1032539206,neutral,0.9294742941856384
207,8/10/2023 3:00:38 PM,What 8 Analyst Ratings Have To Say About Insulet,Benzinga,/news/stocks/what-8-analyst-ratings-have-to-say-about-insulet-1032540530,positive,0.9452075958251953
208,8/11/2023 8:52:36 AM,"Uber Crowded, Battleground and Sweet 16 stock portfolios from Jefferies",Seeking Alpha,https://seekingalpha.com/news/3999208-uber-crowded-battleground-and-sweet-16-stock-portfolios-from-jefferies?utm_source=businessinsider&utm_medium=referral,positive,0.8961217403411865
209,8/17/2023 8:14:29 PM,"JP Morgan Bullish On Insulet, Forecasts Robust Pump Market with Long Runway for Growth",Benzinga,/news/stocks/jp-morgan-bullish-on-insulet-forecasts-robust-pump-market-with-long-runway-for-growth-1032564440,negative,0.9347805976867676
210,8/21/2023 3:01:56 PM,NVIDIA To Rally Over 80%? Here Are 10 Other Analyst Forecasts For Monday,Benzinga,/news/stocks/nvidia-to-rally-over-80-here-are-10-other-analyst-forecasts-for-monday-1032569754,positive,0.9140933156013489
211,8/21/2023 4:09:36 PM,Insulet downgraded at Baird; upgraded at Citi amid GLP1-linked selloff,Seeking Alpha,https://seekingalpha.com/news/4004840-insulet-downgraded-baird-upgraded-citi-amid-glp1-linked-selloff?utm_source=businessinsider&utm_medium=referral,neutral,0.6823350191116333
212,8/21/2023 5:00:26 PM,"Benzinga's Top Ratings Upgrades, Downgrades For August 21, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-august-21-2023-1032570447,neutral,0.49205657839775085
213,8/24/2023 10:32:11 AM,"Analysts Are Bullish on These Healthcare Stocks: Insulet (PODD), Arcus Biosciences (RCUS)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-insulet-podd-arcus-biosciences-rcus-1032579254,positive,0.6210421919822693
214,8/24/2023 7:00:16 PM,Morgan Stanley Maintains Equal-Weight Rating for Insulet: Here's What You Need To Know,Benzinga,/news/stocks/morgan-stanley-maintains-equal-weight-rating-for-insulet-here-s-what-you-need-to-know-1032580842,positive,0.9305137991905212
215,8/30/2023 2:11:37 PM,Insulet spikes as CEO buys over $1M shares,Seeking Alpha,https://seekingalpha.com/news/4007474-insulet-stock-spikes-ceo-buys-1m-shares?utm_source=businessinsider&utm_medium=referral,negative,0.6345158219337463
216,8/30/2023 2:51:51 PM,"Insulet gains amid winning TRO in dispute with EOFlow, CEO insider buy",Seeking Alpha,https://seekingalpha.com/news/4007502-insulet-gains-amid-winning-tro-in-dispute-with-eoflow?utm_source=businessinsider&utm_medium=referral,neutral,0.49895980954170227
217,8/30/2023 4:37:42 PM,"Hovnanian Enterprises, LexinFintech Holdings And Other Big Stocks Moving Higher On Wednesday",Benzinga,/news/stocks/hovnanian-enterprises-lexinfintech-holdings-and-other-big-stocks-moving-higher-on-wednesday-1032593508,negative,0.9371784329414368
218,9/1/2023 10:00:11 PM,The 3 Most Promising Healthcare Stocks to Own Now,InvestorPlace,/news/stocks/the-3-most-promising-healthcare-stocks-to-own-now-1032600808,positive,0.6742458343505859
219,9/4/2023 4:00:00 PM,AI to represent 11% of healthcare budgets in 2024 - Morgan Stanley,Seeking Alpha,https://seekingalpha.com/news/4008712-ai-eleven-percent-healthcare-budgets-2024-morgan-stanley?utm_source=businessinsider&utm_medium=referral,positive,0.8714701533317566
220,9/6/2023 4:00:19 PM,What 12 Analyst Ratings Have To Say About Insulet,Benzinga,/news/stocks/what-12-analyst-ratings-have-to-say-about-insulet-1032609727,positive,0.9468916654586792
221,9/7/2023 5:38:45 PM,"Insulet, Tandem Diabetes drop as weight loss drugs impact insulin use",Seeking Alpha,https://seekingalpha.com/news/4010020-insulet-tandem-drop-weight-loss-drugs-hurt-insulin-use?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9519874453544617
222,9/7/2023 7:19:11 PM,Why Toro Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session,Benzinga,/news/stocks/why-toro-are-trading-lower-by-14-here-are-other-stocks-moving-in-thursday-s-mid-day-session-1032614076,neutral,0.5462777018547058
223,9/15/2023 7:46:54 PM,Apple Taps Seasoned Executive To Head 'Secret' Team Developing Glucose Monitoring Device - Stocks To Watch,Benzinga,/news/stocks/apple-taps-seasoned-executive-to-head-secret-team-developing-glucose-monitoring-device---stocks-to-watch-1032634559,positive,0.7313306331634521
224,9/15/2023 9:44:04 PM,The 7 Most Undervalued Stocks in the Market Right Now: September 2023,InvestorPlace,/news/stocks/the-7-most-undervalued-stocks-in-the-market-right-now-september-2023-1032634778,positive,0.5563452243804932
225,9/27/2023 6:04:52 PM,"September's Shakeout: S&P 500, Nasdaq 100 See Just 13% Of Stocks Above 50-Day Average",Benzinga,/news/etf/september-s-shakeout-s-p-500-nasdaq-100-see-just-13-of-stocks-above-50-day-average-1032660395,positive,0.5685656070709229
226,9/29/2023 3:00:23 PM,14 Analysts Have This to Say About Insulet,Benzinga,/news/stocks/14-analysts-have-this-to-say-about-insulet-1032666419,positive,0.9324402213096619
227,10/2/2023 2:58:57 PM,FedEx To Rally Around 19%? Here Are 10 Other Analyst Forecasts For Monday,Benzinga,/news/stocks/fedex-to-rally-around-19-here-are-10-other-analyst-forecasts-for-monday-1032670357,positive,0.9191283583641052
228,10/2/2023 5:00:30 PM,"Benzinga's Top Ratings Upgrades, Downgrades For October 2, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-october-2-2023-1032671049,positive,0.5131106376647949
229,10/4/2023 11:04:29 AM,"Analysts Offer Insights on Healthcare Companies: PMV Pharmaceuticals (PMVP), Insulet (PODD) and RegenXBio (RGNX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-pmv-pharmaceuticals-pmvp-insulet-podd-and-regenxbio-rgnx-1032677458,positive,0.8976332545280457
230,10/16/2023 9:46:23 AM,BTIG Keeps Their Buy Rating on Insulet (PODD),TipRanks,/news/stocks/btig-keeps-their-buy-rating-on-insulet-podd-1032707660,positive,0.9066213369369507
231,10/16/2023 10:00:17 PM,Expert Ratings for Insulet,Benzinga,/news/stocks/expert-ratings-for-insulet-1032709837,positive,0.8909010291099548
232,10/23/2023 12:19:55 PM,Insulet Gets FDA Clearance For Omnipod 5 App For IPhone - Quick Facts ,RTTNews,/news/stocks/insulet-gets-fda-clearance-for-omnipod-5-app-for-iphone-quick-facts-1032728217,negative,0.8444130420684814
233,10/24/2023 10:37:24 AM,Insulet’s Competitive Edge Strengthened by Omnipod 5 App Clearance: A Comprehensive Analysis,TipRanks,/news/stocks/insulet-s-competitive-edge-strengthened-by-omnipod-5-app-clearance-a-comprehensive-analysis-1032735271,negative,0.8339464664459229
234,10/25/2023 6:17:22 AM,Insulet’s Market Advantage: FDA Clearance for Omnipod 5 iPhone App Bolsters Buy Rating,TipRanks,/news/stocks/insulet-s-market-advantage-fda-clearance-for-omnipod-5-iphone-app-bolsters-buy-rating-1032740153,negative,0.9546331763267517
235,11/1/2023 3:01:13 PM,Insulet earnings preview: what to expect,Markets Insider Automation,/news/stocks/insulet-q3-earnings-preview-stock-1032765684,positive,0.9085105657577515
236,11/3/2023 2:36:47 AM,Insulet’s Significant Growth and Positive Outlook Justify ‘Buy’ Rating: An Analysis of Q3 Performance and Future Prospects,TipRanks,/news/stocks/insulet-s-significant-growth-and-positive-outlook-justify-buy-rating-an-analysis-of-q3-performance-and-future-prospects-1032776510,positive,0.8511183261871338
237,11/3/2023 2:56:48 AM,Insulet’s Strong Q3 Performance and Future Growth Prospects Drive Buy Rating,TipRanks,/news/stocks/insulet-s-strong-q3-performance-and-future-growth-prospects-drive-buy-rating-1032776549,negative,0.9335824251174927
238,11/3/2023 10:40:55 AM,Piper Sandler Reaffirms Their Buy Rating on Insulet (PODD),TipRanks,/news/stocks/piper-sandler-reaffirms-their-buy-rating-on-insulet-podd-1032777750,positive,0.8380930423736572
239,11/3/2023 11:30:32 AM,"Analysts Offer Insights on Healthcare Companies: R1 RCM (RCM), Arcellx Inc (ACLX) and Insulet (PODD)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-r1-rcm-rcm-arcellx-inc-aclx-and-insulet-podd-1032777840,positive,0.9141747951507568
240,11/3/2023 12:25:51 PM,Strong Q3 Performance and Projected Growth Boost Insulet (PODD) Stock: A Buy Recommendation,TipRanks,/news/stocks/strong-q3-performance-and-projected-growth-boost-insulet-podd-stock-a-buy-recommendation-1032777947,negative,0.7195336222648621
241,11/3/2023 4:30:22 PM,"Expedia Group, Gartner, Cloudflare, Cardinal Health And Other Big Stocks Moving Higher On Friday",Benzinga,/news/stocks/expedia-group-gartner-cloudflare-cardinal-health-and-other-big-stocks-moving-higher-on-friday-1032776924,negative,0.9245980381965637
242,11/6/2023 5:59:18 AM,Insulet’s Impressive 3Q23 Performance and Promising Outlook Drive Buy Recommendation Despite GLP-1 Market Impact,TipRanks,/news/stocks/insulet-s-impressive-3q23-performance-and-promising-outlook-drive-buy-recommendation-despite-glp-1-market-impact-1032783278,negative,0.9526860117912292
243,11/7/2023 2:12:26 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Baxter International (BAX), Alnylam Pharma (ALNY) and Insulet (PODD)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-baxter-international-bax-alnylam-pharma-alny-and-insulet-podd-1032788118,neutral,0.9221303462982178
244,11/7/2023 7:13:04 PM,What Stocks Drove The Recent Record Rally? A Breakdown You Can't Miss,Benzinga,/news/etf/what-stocks-drove-the-recent-record-rally-a-breakdown-you-can-t-miss-1032789352,positive,0.8111971616744995
245,11/13/2023 7:35:20 PM,"Stocks Pause Ahead Of CPI Report; Commodities, Tesla, Boeing Surge On Rising China Hopes: What's Driving Markets Monday?",Benzinga,/news/etf/stocks-pause-ahead-of-cpi-report-commodities-tesla-boeing-surge-on-rising-china-hopes-what-s-driving-markets-monday-1032814290,positive,0.5582394003868103
246,11/28/2023 11:30:21 AM,"Analysts’ Top Healthcare Picks: Barinthus Biotherapeutics (BRNS), Anavex Life Sciences (AVXL)",TipRanks,/news/stocks/analysts-top-healthcare-picks-barinthus-biotherapeutics-brns-anavex-life-sciences-avxl-1032856554,negative,0.5993205308914185
247,12/4/2023 2:00:44 PM,What 8 Analyst Ratings Have To Say About Insulet,Benzinga,/news/stocks/what-8-analyst-ratings-have-to-say-about-insulet-1032870229,positive,0.9452075958251953
248,12/6/2023 10:25:28 PM,Insulet’s Market Dominance Strengthens with Legal Victories and Competitive Advantages: A Buy Recommendation Reiterated,TipRanks,/news/stocks/insulet-s-market-dominance-strengthens-with-legal-victories-and-competitive-advantages-a-buy-recommendation-reiterated-1032881189,negative,0.92970210313797
249,12/7/2023 10:40:20 AM,Analysts Offer Insights on Healthcare Companies: Insulet (PODD) and AbbVie (ABBV),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-insulet-podd-and-abbvie-abbv-1032883720,positive,0.9110694527626038
250,12/11/2023 9:32:00 PM,"These 2 MedTech Stocks Look Too Cheap to Ignore, Says Morgan Stanley",TipRanks,/news/stocks/these-2-medtech-stocks-look-too-cheap-to-ignore-says-morgan-stanley-1032892306,neutral,0.6726062297821045
251,12/13/2023 12:56:34 PM,Insulet (PODD) Receives a Buy from Wells Fargo,TipRanks,/news/stocks/insulet-podd-receives-a-buy-from-wells-fargo-1032899051,positive,0.5113739371299744
252,12/21/2023 1:00:23 PM,Expert Ratings For Insulet,Benzinga,/news/stocks/expert-ratings-for-insulet-1032918859,positive,0.8909010291099548
253,12/21/2023 1:36:23 PM,Amazon.com To Rally Over 38%? Here Are 10 Top Analyst Forecasts For Thursday,Benzinga,/news/stocks/amazon-com-to-rally-over-38-here-are-10-top-analyst-forecasts-for-thursday-1032919021,positive,0.914065957069397
254,12/31/2023 10:22:32 AM,Insulet (PODD) Gets a Buy from BTIG,TipRanks,/news/stocks/insulet-podd-gets-a-buy-from-btig-1032934349,positive,0.778218150138855
255,1/2/2024 2:28:05 PM,BTIG Remains a Buy on Insulet (PODD),TipRanks,/news/stocks/btig-remains-a-buy-on-insulet-podd-1032938317,positive,0.9441076517105103
256,1/7/2024 10:38:28 AM,BTIG Reaffirms Their Buy Rating on Insulet (PODD),TipRanks,/news/stocks/btig-reaffirms-their-buy-rating-on-insulet-podd-1032948122,positive,0.7979154586791992
257,1/25/2024 12:32:42 PM,"Analysts Offer Insights on Healthcare Companies: Insulet (PODD), Resmed (RMD) and Clinigence Holdings (NUTX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-insulet-podd-resmed-rmd-and-clinigence-holdings-nutx-1032997665,positive,0.9152241945266724
258,2/7/2024 3:11:06 PM,Insulet gets CE Mark for Ominipod 5 with FreeStyle Libre 2 sensor,Seeking Alpha,https://seekingalpha.com/news/4063877-insulet-gets-ce-mark-for-ominipod-5-with-freestyle-libre-2-sensor?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6019042134284973
259,2/21/2024 3:01:13 PM,Insulet is about to announce its earnings — here's what to expect,Markets Insider Automation,/news/stocks/insulet-stock-price-quarter-earnings-preview-q4-1033087734,positive,0.9399052262306213
260,2/21/2024 10:35:23 PM,Insulet Q4 2023 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/4069811-insulet-q4-2023-earnings-preview?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9191876649856567
261,2/22/2024 9:33:22 PM,"Insulet Non-GAAP EPS of $1.40 beats by $0.74, revenue of $509.8M beats by $48.74M",Seeking Alpha,https://seekingalpha.com/news/4070679-insulet-non-gaap-eps-of-1_40-beats-0_74-revenue-of-509_8m-beats-48_74m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6957823634147644
262,2/23/2024 5:20:08 AM,"Analysts Offer Insights on Healthcare Companies: Insulet (PODD), Teleflex (TFX) and Madrigal Pharmaceuticals (MDGL)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-insulet-podd-teleflex-tfx-and-madrigal-pharmaceuticals-mdgl-1033096241,positive,0.9029929637908936
263,2/23/2024 10:55:37 AM,Insulet’s Strong Performance and Promising Outlook Merit a Buy Rating,TipRanks,/news/stocks/insulet-s-strong-performance-and-promising-outlook-merit-a-buy-rating-1033097454,negative,0.9500998258590698
264,2/23/2024 12:11:19 PM,"Analysts’ Top Healthcare Picks: BioMarin Pharmaceutical (BMRN), Cogent Biosciences (COGT)",TipRanks,/news/stocks/analysts-top-healthcare-picks-biomarin-pharmaceutical-bmrn-cogent-biosciences-cogt-1033098005,negative,0.6447577476501465
265,2/23/2024 12:20:43 PM,Piper Sandler Remains a Buy on Insulet (PODD),TipRanks,/news/stocks/piper-sandler-remains-a-buy-on-insulet-podd-1033098124,positive,0.9468927383422852
266,2/23/2024 12:20:52 PM,"Analysts Offer Insights on Healthcare Companies: Bausch Health Companies (BHC), Insulet (PODD) and Teleflex (TFX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-bausch-health-companies-bhc-insulet-podd-and-teleflex-tfx-1033098121,positive,0.9170644879341125
267,2/23/2024 12:40:34 PM,"Analysts Offer Insights on Healthcare Companies: C4 Therapeutics (CCCC), Insulet (PODD) and Healthequity (HQY)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-c4-therapeutics-cccc-insulet-podd-and-healthequity-hqy-1033098191,positive,0.9020838141441345
268,2/23/2024 12:51:02 PM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Penumbra (PEN), BioMarin Pharmaceutical (BMRN) and Insulet (PODD)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-penumbra-pen-biomarin-pharmaceutical-bmrn-and-insulet-podd-1033098283,neutral,0.731520414352417
269,2/23/2024 8:00:18 PM,Analyst Scoreboard: 5 Ratings For Insulet,Benzinga,/news/stocks/analyst-scoreboard-5-ratings-for-insulet-1033098839,positive,0.8967345952987671
270,2/26/2024 1:15:06 AM,Barclays Sticks to Its Hold Rating for Insulet (PODD),TipRanks,/news/stocks/barclays-sticks-to-its-hold-rating-for-insulet-podd-1033100067,positive,0.8206930160522461
271,2/26/2024 4:36:01 AM,Insulet’s Strong Growth and Market Position Justify Buy Rating Despite Short-Term Revenue Guidance Concerns,TipRanks,/news/stocks/insulet-s-strong-growth-and-market-position-justify-buy-rating-despite-short-term-revenue-guidance-concerns-1033101082,negative,0.9467697143554688
272,2/26/2024 4:40:28 AM,"Analysts Are Bullish on These Healthcare Stocks: IDEAYA Biosciences (IDYA), Insulet (PODD)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-ideaya-biosciences-idya-insulet-podd-1033101071,positive,0.7851085662841797
273,2/26/2024 5:18:57 PM,"Surgery Partners Posts Weak Sales, Joins Kosmos Energy, Moderna And Other Big Stocks Moving Lower On Monday",Benzinga,/news/stocks/surgery-partners-posts-weak-sales-joins-kosmos-energy-moderna-and-other-big-stocks-moving-lower-on-monday-1033103645,neutral,0.9725202918052673
274,2/29/2024 11:00:45 PM,Top Stocks Not Named Nvidia You Need To Know About In 2024: Here's What Investors Think About Them (Wall Street Vs. Reddit),Benzinga,/news/stocks/top-stocks-not-named-nvidia-you-need-to-know-about-in-2024-here-s-what-investors-think-about-them-wall-street-vs-reddit-1033120683,positive,0.9334502816200256
275,3/3/2024 7:54:47 PM,Stocks with the most insider buying and selling,Seeking Alpha,https://seekingalpha.com/news/4075017-stocks-with-the-most-insider-buying-and-selling?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9083901643753052
276,3/7/2024 11:00:28 AM,Analysts’ Opinions Are Mixed on These Healthcare Stocks: Insulet (PODD) and Adaptimmune Therapeutics (ADAP),TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-insulet-podd-and-adaptimmune-therapeutics-adap-1033142394,neutral,0.6856931447982788
277,3/8/2024 1:43:37 PM,Insulet Omnipod 5 insulin pump bests conventional delivery systems,Seeking Alpha,https://seekingalpha.com/news/4077624-insulet-omnipod-5-insulin-patch-bests-pump-delivery-systems?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8757206797599792
278,3/16/2024 4:15:16 PM,Insulet’s Growth Trajectory Affirmed with a Buy Rating and Revised Target Price,TipRanks,/news/stocks/insulet-s-growth-trajectory-affirmed-with-a-buy-rating-and-revised-target-price-1033169880,negative,0.8495340347290039
279,3/20/2024 10:46:19 AM,Insulet names Ana Maria Chadwick as finance chief,Seeking Alpha,https://seekingalpha.com/news/4081479-insulet-names-ana-maria-chadwick-as-finance-chief?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.950985848903656
280,3/20/2024 11:13:16 AM,"Insulet Names Ana Maria Chadwick CFO, Effective April 22 ",RTTNews,/news/stocks/insulet-names-ana-maria-chadwick-cfo-effective-april-22-1033179655,positive,0.9138021469116211
281,3/21/2024 11:40:15 AM,"Analysts Are Bullish on These Healthcare Stocks: Insulet (PODD), Annovis Bio (ANVS)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-insulet-podd-annovis-bio-anvs-1033185173,positive,0.7206207513809204
282,3/22/2024 11:20:20 AM,"Analysts Offer Insights on Healthcare Companies: Insulet (PODD), Biomea Fusion (BMEA) and Soleno Therapeutics (SLNO)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-insulet-podd-biomea-fusion-bmea-and-soleno-therapeutics-slno-1033188881,positive,0.8979106545448303
283,3/26/2024 1:29:13 PM,Tandem Diabetes raised to Buy at Stifel on Mobi launch,Seeking Alpha,https://seekingalpha.com/news/4083704-tandem-diabetes-stock-raised-buy-stifel?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6235857009887695
284,3/30/2024 4:13:00 PM,Eli Lilly tops S&P 500 healthcare sector in Q1 as weight loss frenzy continues,Seeking Alpha,https://seekingalpha.com/news/4084974-eli-lilly-tops-the-growth-chart-for-the-sp-500-index-in-q1-as-the-sector-gains-momentum?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6530331969261169
285,4/4/2024 3:12:55 PM,Top buy-rated stocks and sell-rated stocks within Health Care - Citi,Seeking Alpha,https://seekingalpha.com/news/4087312-top-buy-rated-stocks-and-sell-rated-stocks-within-health-care-citi?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9045203924179077
286,4/15/2024 1:45:30 PM,7 Stable Stocks for 50% Returns by Early 2025,InvestorPlace,/news/stocks/7-stable-stocks-for-50-returns-by-early-2025-1033249498,negative,0.7303330302238464
287,4/17/2024 8:30:36 AM,3 Weight-Loss ETFs to Profit From the Obesity Drug Boom,InvestorPlace,/news/stocks/3-weight-loss-etfs-to-profit-from-the-obesity-drug-boom-1033256825,positive,0.5709972977638245
288,4/29/2024 1:24:45 PM,"DexCom, Insulet, Tandem seen benefitting the most in diabetes survey - Wells Fargo",Seeking Alpha,https://seekingalpha.com/news/4095444-dexcom-insulet-tandem-benefitting-most-diabetes-survey?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8844127655029297
289,5/7/2024 9:19:51 AM,Insulet’s Market Dominance and Growth Catalysts Prompt ‘Buy’ Rating,TipRanks,/news/stocks/insulet-s-market-dominance-and-growth-catalysts-prompt-buy-rating-1033338987,negative,0.8825584650039673
290,5/7/2024 3:00:14 PM,4 Analysts Assess Insulet: What You Need To Know,Benzinga,/news/stocks/4-analysts-assess-insulet-what-you-need-to-know-1033339664,positive,0.9286704659461975
291,5/7/2024 3:56:38 PM,"Wolfe raises Insulet to outperform, cites increasing market share",Seeking Alpha,https://seekingalpha.com/news/4101345-wolfe-raises-insulet-to-outperform-cites-increasing-market-share?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9514274001121521
292,5/8/2024 3:01:13 PM,Insulet earnings: here's what Wall Street expects,Markets Insider Automation,/news/stocks/insulet-q1-earnings-preview-stock-1033347194,positive,0.9279787540435791
293,5/8/2024 9:20:22 PM,Insulet Q1 2024 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/4102674-insulet-q1-2024-earnings-preview?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9227529764175415
294,5/8/2024 9:35:55 PM,Notable earnings after Thursday's close,Seeking Alpha,https://seekingalpha.com/news/4102516-notable-earnings-after-thursdays-close?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8900269269943237
295,5/9/2024 8:24:28 PM,"Insulet Non-GAAP EPS of $0.23 misses by $0.16, revenue of $441.7M beats by $18.21M",Seeking Alpha,https://seekingalpha.com/news/4104093-insulet-non-gaap-eps-of-0_23-misses-0_16-revenue-of-441_7m-beats-18_21m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7051604986190796
296,5/10/2024 12:57:48 AM,"PODD Stock Earnings: Insulet Beats EPS, Beats Revenue for Q1 2024",InvestorPlace,/news/stocks/podd-stock-earnings-insulet-for-q1-of-2024-1033359004,negative,0.5894054174423218
297,5/10/2024 9:57:38 AM,Insulet Corporation: Strong Q1 Performance and Positive Growth Outlook Affirm Buy Rating,TipRanks,/news/stocks/insulet-corporation-strong-q1-performance-and-positive-growth-outlook-affirm-buy-rating-1033362856,negative,0.9498850703239441
298,5/10/2024 10:00:11 AM,Insulet’s Upbeat Performance and Future Outlook Justify a Buy Rating,TipRanks,/news/stocks/insulet-s-upbeat-performance-and-future-outlook-justify-a-buy-rating-1033363023,negative,0.9380837082862854
299,5/10/2024 12:04:24 PM,Insulet (PODD) Gets a Buy from Piper Sandler,TipRanks,/news/stocks/insulet-podd-gets-a-buy-from-piper-sandler-1033363914,negative,0.6633825302124023
300,5/10/2024 3:17:29 PM,Bank of America Securities Reaffirms Their Buy Rating on Insulet (PODD),TipRanks,/news/stocks/bank-of-america-securities-reaffirms-their-buy-rating-on-insulet-podd-1033364625,positive,0.8385281562805176
301,5/10/2024 6:45:53 PM,"Stocks Pause On Dismal Consumer Confidence; Yields, Dollar Rise As Inflation Expectations Kick Higher, Bitcoin Sinks: What's Driving Markets Friday? (CORRECTED)",Benzinga,/news/stocks/stocks-pause-on-dismal-consumer-confidence-yields-dollar-rise-as-inflation-expectations-kick-higher-bitcoin-sinks-what-s-driving-markets-friday-1033364402,neutral,0.7250726819038391
302,5/13/2024 1:20:05 AM,Analysts Conflicted on These Healthcare Names: Insulet (PODD) and Progyny (PGNY),TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-insulet-podd-and-progyny-pgny-1033366426,neutral,0.6658385396003723
303,5/13/2024 2:07:20 AM,Insulet (PODD) Gets a Hold from Stifel Nicolaus,TipRanks,/news/stocks/insulet-podd-gets-a-hold-from-stifel-nicolaus-1033366960,positive,0.7815450429916382
304,5/13/2024 3:25:22 PM,Insulet’s Strong Financial Performance and Strategic Developments Merit a Buy Rating,TipRanks,/news/stocks/insulet-s-strong-financial-performance-and-strategic-developments-merit-a-buy-rating-1033372342,negative,0.947857141494751
305,5/14/2024 9:40:09 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Mersana Therapeutics (MRSN), Insulet (PODD) and Crispr Therapeutics AG (CRSP)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-mersana-therapeutics-mrsn-insulet-podd-and-crispr-therapeutics-ag-crsp-1033376019,neutral,0.9389393329620361
306,5/14/2024 11:30:39 AM,"Analysts Are Bullish on These Healthcare Stocks: Mersana Therapeutics (MRSN), Insulet (PODD)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-mersana-therapeutics-mrsn-insulet-podd-1033377459,positive,0.5797369480133057
307,5/14/2024 7:59:15 PM,"Wall Street Trades Flat On Mixed Producer Inflation; Meme Stocks See Wild Ride, Bitcoin Drops: What's Driving Markets Tuesday?",Benzinga,/news/etf/wall-street-trades-flat-on-mixed-producer-inflation-meme-stocks-see-wild-ride-bitcoin-drops-what-s-driving-markets-tuesday-1033378273,neutral,0.9050607681274414
308,5/16/2024 4:36:28 PM,Insulet’s Strong Market Position and Financial Health Merit a Buy Rating Despite Legal Challenges,TipRanks,/news/stocks/insulet-s-strong-market-position-and-financial-health-merit-a-buy-rating-despite-legal-challenges-1033394940,negative,0.9018549919128418
309,5/19/2024 6:08:39 PM,Follow the Whales: 3 Genius Stocks the Smart Money Is Piling Into for Triple-Digit Gains,InvestorPlace,/news/stocks/follow-the-whales-3-genius-stocks-the-smart-money-is-piling-into-for-triple-digit-gains-1033401772,positive,0.888038158416748
310,5/22/2024 5:55:06 PM,"Citi upgrades Edwards, Tandem; cuts Nevro, Establishment Labs",Seeking Alpha,https://seekingalpha.com/news/4109467-citi-upgrades-edwards-tandem-cuts-nevro-establishment-labs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7632619142532349
311,5/30/2024 2:00:48 PM,Where Insulet Stands With Analysts,Benzinga,/news/stocks/where-insulet-stands-with-analysts-1033435768,positive,0.9071894884109497
312,5/30/2024 5:39:13 PM,"Insulet, Tandem new buys from Redburn Atlantic in diabetes technology space",Seeking Alpha,https://seekingalpha.com/news/4111650-insulet-tandem-new-buys-redburn-atlantic-diabetes-technology-space?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7618010640144348
313,5/31/2024 3:20:08 AM,Analysts Offer Insights on Healthcare Companies: Insulet (PODD) and Ultragenyx Pharmaceutical (RARE),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-insulet-podd-and-ultragenyx-pharmaceutical-rare-1033439855,positive,0.8914163708686829
314,6/4/2024 9:40:45 AM,"Analysts Are Bullish on These Healthcare Stocks: Insulet (PODD), Gilead Sciences (GILD)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-insulet-podd-gilead-sciences-gild-1033449290,positive,0.6214597821235657
315,6/5/2024 3:21:33 PM,The most crowded longs and shorts in U.S. Med-Tech for May - UBS,Seeking Alpha,https://seekingalpha.com/news/4113240-the-most-crowded-longs-and-shorts-in-us-med-tech-for-may-ubs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8358550071716309
316,6/6/2024 10:19:00 AM,7 Stocks That Could Safely 10X by 2030,InvestorPlace,/news/stocks/7-stocks-that-could-safely-10x-by-2030-1033456760,positive,0.5836676359176636
317,6/19/2024 10:02:00 AM,The 3 Best Diabetes Stocks to Buy in June 2024,InvestorPlace,/news/stocks/the-3-best-diabetes-stocks-to-buy-in-june-2024-1033489895,positive,0.8979547619819641
318,6/24/2024 10:19:24 AM,Buy Rating Affirmed for Insulet: Integration of G7 System and Strong Market Strategy Promises Robust Growth,TipRanks,/news/stocks/buy-rating-affirmed-for-insulet-integration-of-g7-system-and-strong-market-strategy-promises-robust-growth-1033500008,negative,0.9524919390678406
319,6/24/2024 11:55:22 AM,TD Cowen Sticks to Their Buy Rating for Insulet (PODD),TipRanks,/news/stocks/td-cowen-sticks-to-their-buy-rating-for-insulet-podd-1033500663,positive,0.8426828980445862
320,6/24/2024 11:55:48 AM,Jefferies Reaffirms Their Buy Rating on Insulet (PODD),TipRanks,/news/stocks/jefferies-reaffirms-their-buy-rating-on-insulet-podd-1033500656,positive,0.8273366093635559
321,6/24/2024 4:06:59 PM,"Tandem Diabetes, DexCom see weakness following ADA conference",Seeking Alpha,https://seekingalpha.com/news/4118441-tandem-diabetes-dexcom-see-weakness-following-ada-conference?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7187515497207642
322,6/28/2024 1:25:41 PM,Insulet’s Market Expansion and Innovative Growth Poised for Buy Rating,TipRanks,/news/stocks/insulet-s-market-expansion-and-innovative-growth-poised-for-buy-rating-1033516163,negative,0.8860048651695251
323,6/29/2024 3:35:00 PM,Insulet tops S&P 500 growth chart for Q2 as it gains market share in the diabetes space,Seeking Alpha,https://seekingalpha.com/news/4120025-insulet-tops-sp-500-growth-chart-for-q2-as-it-gains-market-share-in-the-diabetes-space?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9450204372406006
324,7/10/2024 4:52:04 PM,Glaukos cut as Citi reviews U.S. MedTechs ahead of Q2 results,Seeking Alpha,https://seekingalpha.com/news/4123355-glaukos-cut-as-citi-reviews-us-medtechs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8797835111618042
325,7/23/2024 10:46:01 AM,Insulet’s Growth Prospects Bolstered by AID Technology and Strategic Market Expansion,TipRanks,/news/stocks/insulet-s-growth-prospects-bolstered-by-aid-technology-and-strategic-market-expansion-1033582847,negative,0.9366862773895264
326,7/23/2024 2:00:39 PM,A Closer Look at 7 Analyst Recommendations For Insulet,Benzinga,/news/stocks/a-closer-look-at-7-analyst-recommendations-for-insulet-1033582098,positive,0.9043653607368469
327,7/26/2024 10:21:41 AM,Insulet's prelim Q2 revenue tops estimates,Seeking Alpha,https://seekingalpha.com/news/4128834-insulet-stock-falls-even-as-prelim-q2-revenue-tops-estimates?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7406311631202698
328,7/26/2024 12:36:23 PM,Insulet Preliminary Q2 Revenue Rises; Stock Up In Pre-Market ,RTTNews,/news/stocks/insulet-preliminary-q2-revenue-rises-stock-up-in-pre-market-1033599525,negative,0.9435696601867676
329,7/26/2024 7:55:04 PM,DexCom reaches a multi-year low as downgrades follow guidance cut,Seeking Alpha,https://seekingalpha.com/news/4129136-dexcom-stock-falls-downgrades-guidance-cut?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.966895341873169
330,7/30/2024 5:58:19 AM,Insulet Poised for Continued Growth: Strong Q2 Performance and Omnipod Demand Fuel Buy Rating,TipRanks,/news/stocks/insulet-poised-for-continued-growth-strong-q2-performance-and-omnipod-demand-fuel-buy-rating-1033610671,negative,0.9504455924034119
331,8/7/2024 12:35:41 PM,Abbott to integrate CGM with Medtronic's insulin delivery devices,Seeking Alpha,https://seekingalpha.com/news/4135909-abbott-to-integrate-cgm-system-with-medtronics-insulin-delivery-devices?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6433109641075134
332,8/7/2024 3:01:13 PM,Insulet earnings preview: what to expect,Markets Insider Automation,/news/stocks/insulet-stock-quarter-earnings-preview-q2-1033652904,positive,0.9085105657577515
333,8/8/2024 11:50:22 AM,Wall Street Analysts Are Bullish on Top Healthcare Picks,TipRanks,/news/stocks/wall-street-analysts-are-bullish-on-top-healthcare-picks-1033661534,negative,0.5521676540374756
334,8/8/2024 2:45:00 PM,Insulet Corp Shs hosts conference call for investors,Markets Insider Automation,/news/stocks/insulet_conference-1031775646,positive,0.9412566423416138
335,8/8/2024 8:03:16 PM,"Insulet Non-GAAP EPS of $0.55 misses by $0.01, revenue of $488.5M beats by $27.13M",Seeking Alpha,https://seekingalpha.com/news/4137486-insulet-non-gaap-eps-of-0_55-misses-0_01-revenue-of-488_5m-beats-27_13m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5824156999588013
336,8/8/2024 10:59:58 PM,"Insulet Corp. Q2 Profit Increases, But Misses Estimates ",RTTNews,/news/stocks/insulet-corp-q2-profit-increases-but-misses-estimates-1033663487,negative,0.8848657608032227
337,8/9/2024 12:59:16 AM,"PODD Stock Earnings: Insulet Misses EPS, Beats Revenue for Q2 2024",InvestorPlace,/news/stocks/podd-stock-earnings-insulet-for-q2-of-2024-1033663840,neutral,0.6715191006660461
338,8/9/2024 1:35:39 AM,Buy Rating Affirmed: Insulet’s Strong Performance and Growth Potential,TipRanks,/news/stocks/buy-rating-affirmed-insulet-s-strong-performance-and-growth-potential-1033666780,negative,0.9514293670654297
339,8/9/2024 12:33:09 PM,Steed Reiterates Buy Rating on Insulet Amid Positive Growth Trajectory and Strategic G7 Rollout,TipRanks,/news/stocks/steed-reiterates-buy-rating-on-insulet-amid-positive-growth-trajectory-and-strategic-g7-rollout-1033670040,negative,0.9379839301109314
340,8/9/2024 12:50:20 PM,Piper Sandler Releases a Buy Rating on Insulet (PODD),TipRanks,/news/stocks/piper-sandler-releases-a-buy-rating-on-insulet-podd-1033670146,positive,0.9063512682914734
341,8/9/2024 1:00:33 PM,Oppenheimer Reaffirms Their Buy Rating on Insulet (PODD),TipRanks,/news/stocks/oppenheimer-reaffirms-their-buy-rating-on-insulet-podd-1033670296,positive,0.8605620861053467
342,8/9/2024 1:04:55 PM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: CVS Health (CVS), Insulet (PODD) and Artivion (AORT)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-cvs-health-cvs-insulet-podd-and-artivion-aort-1033670277,neutral,0.7469012141227722
343,8/9/2024 1:19:46 PM,Stifel Nicolaus Sticks to Their Hold Rating for Insulet (PODD),TipRanks,/news/stocks/stifel-nicolaus-sticks-to-their-hold-rating-for-insulet-podd-1033670411,positive,0.7732564806938171
344,8/9/2024 1:28:40 PM,Jefferies Reaffirms Their Buy Rating on Insulet (PODD),TipRanks,/news/stocks/jefferies-reaffirms-their-buy-rating-on-insulet-podd-1033670515,positive,0.8273366093635559
345,8/12/2024 7:50:32 AM,Barclays Sticks to Their Hold Rating for Insulet (PODD),TipRanks,/news/stocks/barclays-sticks-to-their-hold-rating-for-insulet-podd-1033676438,positive,0.8663560748100281
346,8/13/2024 4:31:44 PM,"Analysts Offer Insights on Healthcare Companies: Insulet (PODD), Carisma Therapeutics (CARM) and Recursion Pharmaceuticals (RXRX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-insulet-podd-carisma-therapeutics-carm-and-recursion-pharmaceuticals-rxrx-1033683705,positive,0.8826014399528503
347,8/13/2024 4:40:36 PM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Insulet (PODD), Recursion Pharmaceuticals (RXRX) and Edgewise Therapeutics (EWTX)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-insulet-podd-recursion-pharmaceuticals-rxrx-and-edgewise-therapeutics-ewtx-1033683699,neutral,0.9405025243759155
348,8/19/2024 7:07:33 PM,Small-cap and mid-cap Health Care has room to rally - Roth MKM,Seeking Alpha,https://seekingalpha.com/news/4141609-small-cap-and-mid-cap-health-care-has-room-to-rally-roth-mkm?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7902520298957825
349,8/21/2024 11:15:26 AM,Insulet (PODD) Gets a Buy from TD Cowen,TipRanks,/news/stocks/insulet-podd-gets-a-buy-from-td-cowen-1033711550,positive,0.4991517663002014
350,8/22/2024 4:41:46 PM,Tandem Diabetes a new equal weight at Morgan Stanley due to competition,Seeking Alpha,https://seekingalpha.com/news/4142983-tandem-diabetes-new-equal-weight-morgan-stanley-due-competition?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7296953201293945
351,8/26/2024 9:26:39 PM,FDA clears Insulet's Omnipod 5 for type 2 diabetes,Seeking Alpha,https://seekingalpha.com/news/4143969-fda-clears-insulet-omnipod-5-for-type-2-diabetes?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.532727837562561
352,8/27/2024 3:19:31 AM,FDA Clears Insulet's Omnipod 5 Automated Insulin Delivery System For People With Type 2 Diabetes ,RTTNews,/news/stocks/fda-clears-insulet-s-omnipod-5-automated-insulin-delivery-system-for-people-with-type-2-diabetes-1033723319,negative,0.5953525900840759
353,8/27/2024 8:47:21 AM,Buy Rating on Insulet: Early FDA Approval and Market Dominance Signal Strong Growth Potential,TipRanks,/news/stocks/buy-rating-on-insulet-early-fda-approval-and-market-dominance-signal-strong-growth-potential-1033725100,negative,0.9533351063728333
354,8/27/2024 10:32:43 AM,Insulet’s Omnipod 5 Expansion into Type 2 Diabetes Market: A Strong Buy Rating,TipRanks,/news/stocks/insulet-s-omnipod-5-expansion-into-type-2-diabetes-market-a-strong-buy-rating-1033725555,negative,0.9444398283958435
355,8/27/2024 10:36:01 AM,Piper Sandler Sticks to Their Buy Rating for Insulet (PODD),TipRanks,/news/stocks/piper-sandler-sticks-to-their-buy-rating-for-insulet-podd-1033725546,positive,0.8683613538742065
356,8/27/2024 10:47:10 AM,Insulet’s Omnipod 5 Expansion into Type 2 Diabetes Market: A Game Changer for Growth,TipRanks,/news/stocks/insulet-s-omnipod-5-expansion-into-type-2-diabetes-market-a-game-changer-for-growth-1033725587,positive,0.6018786430358887
357,8/27/2024 11:15:29 AM,TD Cowen Keeps Their Buy Rating on Insulet (PODD),TipRanks,/news/stocks/td-cowen-keeps-their-buy-rating-on-insulet-podd-1033725984,positive,0.9107084274291992
358,8/27/2024 11:45:55 AM,Oppenheimer Sticks to Its Buy Rating for Insulet (PODD),TipRanks,/news/stocks/oppenheimer-sticks-to-its-buy-rating-for-insulet-podd-1033726046,positive,0.8272476196289062
359,8/27/2024 11:55:39 AM,Jefferies Sticks to Its Buy Rating for Insulet (PODD),TipRanks,/news/stocks/jefferies-sticks-to-its-buy-rating-for-insulet-podd-1033726032,positive,0.8069369196891785
360,8/27/2024 4:27:00 PM,"Biggest stock movers today: PODD, HIMS, PARA, and more",Seeking Alpha,https://seekingalpha.com/news/4144004-biggest-stock-movers-today-para-tcom-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9006218314170837
361,8/27/2024 10:00:03 PM,Insulet's Omnipod 5 Automated Insulin Delivery System Receives FDA Clearance For Type 2 Diabetes ,RTTNews,/news/stocks/insulet-s-omnipod-5-automated-insulin-delivery-system-receives-fda-clearance-for-type-2-diabetes-1033726609,negative,0.8564419150352478
362,8/28/2024 5:35:48 AM,Insulet Stock Buy Rating: FDA Approval Expands Market Reach for Omnipod 5,TipRanks,/news/stocks/insulet-stock-buy-rating-fda-approval-expands-market-reach-for-omnipod-5-1033728035,negative,0.9319206476211548
363,9/3/2024 2:24:32 PM,Embecta gets FDA clearance for type 2 diabetes patch pump,Seeking Alpha,https://seekingalpha.com/news/4146224-embecta-gets-fda-clearance-for-type-2-diabetes-patch-pump?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8641386032104492
364,9/5/2024 9:07:10 AM,Strong Growth and Market Leadership Support Buy Rating for Insulet,TipRanks,/news/stocks/strong-growth-and-market-leadership-support-buy-rating-for-insulet-1033750405,negative,0.9320715665817261
365,9/10/2024 9:59:09 AM,Insulet’s Growth Trajectory Strengthened by Omnipod 5’s Expansion into Type 2 Diabetes Market,TipRanks,/news/stocks/insulet-s-growth-trajectory-strengthened-by-omnipod-5-s-expansion-into-type-2-diabetes-market-1033760516,negative,0.9531040191650391
366,9/17/2024 10:57:35 AM,Piper Sandler Sticks to Its Buy Rating for Insulet (PODD),TipRanks,/news/stocks/piper-sandler-sticks-to-its-buy-rating-for-insulet-podd-1033777809,positive,0.8049731850624084
367,10/1/2024 9:39:53 PM,"BDX upped to buy by Citi, TNDM put on Negative Catalyst Watch",Seeking Alpha,https://seekingalpha.com/news/4155278-bdx-upped-to-buy-by-citi-tndm-put-on-negative-catalyst-watch?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9199478626251221
368,10/4/2024 2:44:52 PM,Medtronic issues recall for MiniMed insulin pumps over battery issues,Seeking Alpha,https://seekingalpha.com/news/4156491-medtronic-issues-recall-for-minimed-insulin-pumps-over-battery-issues?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9180160760879517
369,10/25/2024 5:10:19 PM,"Apple tested blood-sugar app, does not plan to release, Bloomberg says",TipRanks,/news/stocks/apple-tested-blood-sugar-app-does-not-plan-to-release-bloomberg-says-1033895182,positive,0.9309790134429932
370,11/6/2024 10:40:25 AM,Insulet initiated with an Outperform at Bernstein,TipRanks,/news/stocks/insulet-initiated-with-an-outperform-at-bernstein-1033961170,neutral,0.7454283237457275
371,11/6/2024 2:40:44 PM,"Five Below downgraded, Snowflake upgraded: Wall Street’s top analyst calls",TipRanks,/news/stocks/five-below-downgraded-snowflake-upgraded-wall-street-s-top-analyst-calls-1033963373,positive,0.7198277711868286
372,11/6/2024 4:56:17 PM,"Tandem, Insulet draw bullish views at Bernstein ahead of earnings",Seeking Alpha,https://seekingalpha.com/news/4256070-tandem-insulet-stocks-rated-bullish-bernstein?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8682629466056824
373,11/6/2024 10:35:51 PM,Insulet Q3 2024 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/4257384-insulet-q3-2024-earnings-preview?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9154562950134277
374,11/7/2024 3:00:00 PM,Here are the major earnings after the close today,Seeking Alpha,https://seekingalpha.com/news/4255280-here-are-the-major-earnings-after-the-close-today?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9299408793449402
375,11/7/2024 9:09:07 PM,"Insulet Non-GAAP EPS of $0.90 beats by $0.14, revenue of $543.9M beats by $24.62M",Seeking Alpha,https://seekingalpha.com/news/4262815-insulet-non-gaap-eps-of-0_90-beats-0_14-revenue-of-543_9m-beats-24_62m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7443773746490479
376,11/7/2024 9:10:23 PM,"Insulet reports Q3 adjusted EPS 90c, consensus 76c",TipRanks,/news/stocks/insulet-reports-q3-adjusted-eps-90c-consensus-76c-1033974389,positive,0.8847339153289795
377,11/7/2024 9:18:40 PM,Insulet sees FY24 gross margin approximately 69%,TipRanks,/news/stocks/insulet-sees-fy24-gross-margin-approximately-69-1033974491,positive,0.7608602046966553
378,11/7/2024 9:19:32 PM,Insulet sees Q4 revenue growth 12%-15%,TipRanks,/news/stocks/insulet-sees-q4-revenue-growth-12--15-1033974483,negative,0.9423191547393799
379,11/7/2024 9:20:10 PM,Insulet sees FY24 revenue growth 20%-21%,TipRanks,/news/stocks/insulet-sees-fy24-revenue-growth-20--21-1033974477,negative,0.9450977444648743
380,11/8/2024 4:25:29 AM,Insulet’s Strong Market Performance and Growth Justify Buy Rating,TipRanks,/news/stocks/insulet-s-strong-market-performance-and-growth-justify-buy-rating-1033979270,negative,0.861413300037384
381,11/8/2024 4:32:22 AM,Insulet Reports Strong Revenue Growth and Optimistic Outlook,TipRanks,/news/stocks/insulet-reports-strong-revenue-growth-and-optimistic-outlook-1033979441,negative,0.9524585008621216
382,11/8/2024 11:46:04 AM,Insulet’s Promising Growth Trajectory and Strategic Initiatives Signal a Buy Rating,TipRanks,/news/stocks/insulet-s-promising-growth-trajectory-and-strategic-initiatives-signal-a-buy-rating-1033982574,negative,0.949492871761322
383,11/8/2024 12:19:06 PM,Wells Fargo Gives a Buy Rating to Insulet (PODD),TipRanks,/news/stocks/wells-fargo-gives-a-buy-rating-to-insulet-podd-1033983159,positive,0.8410761952400208
384,11/8/2024 12:25:10 PM,Insulet price target raised to $270 from $260 at BTIG,TipRanks,/news/stocks/insulet-price-target-raised-to-270-from-260-at-btig-1033983080,negative,0.9480515122413635
385,11/8/2024 1:45:11 PM,Insulet’s Strong Financial Performance and Strategic Expansion Justify Buy Rating,TipRanks,/news/stocks/insulet-s-strong-financial-performance-and-strategic-expansion-justify-buy-rating-1033983854,negative,0.872938871383667
386,11/8/2024 2:51:35 PM,Bank of America Securities Reaffirms Their Buy Rating on Insulet (PODD),TipRanks,/news/stocks/bank-of-america-securities-reaffirms-their-buy-rating-on-insulet-podd-1033984342,positive,0.8385281562805176
387,11/8/2024 2:55:13 PM,Early notable gainers among liquid option names on November 8th,TipRanks,/news/stocks/early-notable-gainers-among-liquid-option-names-on-november-8th-1033984323,negative,0.8987589478492737
388,11/10/2024 1:42:28 AM,"Analysts Are Bullish on These Healthcare Stocks: Insulet (PODD), Genfit (GNFTF)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-insulet-podd-genfit-gnftf-1033986004,positive,0.5738080143928528
389,11/11/2024 6:15:32 AM,Insulet’s Strong Market Position and Growth Potential Justifies Buy Rating,TipRanks,/news/stocks/insulet-s-strong-market-position-and-growth-potential-justifies-buy-rating-1033990607,negative,0.7071252465248108
390,11/11/2024 6:25:59 AM,Insulet’s Strong Performance and Growth Prospects Justify Buy Rating,TipRanks,/news/stocks/insulet-s-strong-performance-and-growth-prospects-justify-buy-rating-1033990540,negative,0.8516799211502075
391,11/11/2024 8:15:39 AM,Barclays Sticks to Its Hold Rating for Insulet (PODD),TipRanks,/news/stocks/barclays-sticks-to-its-hold-rating-for-insulet-podd-1033991200,positive,0.8206930160522461
392,11/11/2024 11:30:20 AM,Insulet price target raised to $234 from $220 at Barclays,TipRanks,/news/stocks/insulet-price-target-raised-to-234-from-220-at-barclays-1033992229,negative,0.945368766784668
393,11/11/2024 11:45:21 AM,Insulet price target raised to $317 from $234 at Morgan Stanley,TipRanks,/news/stocks/insulet-price-target-raised-to-317-from-234-at-morgan-stanley-1033992366,negative,0.9450682401657104
394,11/20/2024 3:06:06 PM,Insulet Says Omnipod 5 AID System Now Compatible With Abbott's FreeStyle Libre 2 Plus CGM Sensor ,RTTNews,/news/stocks/insulet-says-omnipod-5-aid-system-now-compatible-with-abbott-s-freestyle-libre-2-plus-cgm-sensor-1034042208,negative,0.7979446649551392
395,11/20/2024 3:43:32 PM,Insulet's Omnipod 5 now compatible with Abbott's FreeStyle Libre 2 Plus,Seeking Alpha,https://seekingalpha.com/news/4312299-insulets-omnipod-5-now-compatible-with-abbotts-freestyle-libre-2-plus?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.605710506439209
396,11/21/2024 11:55:29 AM,Insulet’s Strategic Advancements and Market Positioning Drive Buy Rating,TipRanks,/news/stocks/insulet-s-strategic-advancements-and-market-positioning-drive-buy-rating-1034049014,negative,0.8975809812545776
397,11/28/2024 9:25:42 AM,Leerink Partners Keeps Their Buy Rating on Insulet (PODD),TipRanks,/news/stocks/leerink-partners-keeps-their-buy-rating-on-insulet-podd-1034075874,positive,0.908987820148468
398,12/5/2024 3:21:26 PM,Morgan Stanley Sticks to Their Buy Rating for Insulet (PODD),TipRanks,/news/stocks/morgan-stanley-sticks-to-their-buy-rating-for-insulet-podd-1034103568,positive,0.8516759872436523
399,12/5/2024 5:33:23 PM,Insulet awarded $452M in damages in EOFlow case,Seeking Alpha,https://seekingalpha.com/news/4367209-insulet-awarded-452m-in-damages-in-eoflow-case?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.557645320892334
400,12/6/2024 9:50:11 AM,"Analysts’ Top Healthcare Picks: Insulet (PODD), Monte Rosa Therapeutics (GLUE)",TipRanks,/news/stocks/analysts-top-healthcare-picks-insulet-podd-monte-rosa-therapeutics-glue-1034107528,negative,0.6442345976829529
401,12/10/2024 1:15:16 PM,Insulet (PODD) Receives a Buy from Jefferies,TipRanks,/news/stocks/insulet-podd-receives-a-buy-from-jefferies-1034120287,negative,0.4961615800857544
402,12/11/2024 11:45:53 AM,Insulet price target raised to $310 from $283 at Citi,TipRanks,/news/stocks/insulet-price-target-raised-to-310-from-283-at-citi-1034124794,negative,0.9441087245941162
403,12/11/2024 11:55:39 AM,Wells Fargo Keeps Their Buy Rating on Insulet (PODD),TipRanks,/news/stocks/wells-fargo-keeps-their-buy-rating-on-insulet-podd-1034124752,positive,0.910140872001648
404,12/11/2024 2:40:24 PM,"Tandem Diabetes, Insulet views Positive at OTR Global after checks",TipRanks,/news/stocks/tandem-diabetes-insulet-views-positive-at-otr-global-after-checks-1034126167,negative,0.4959462881088257
405,12/12/2024 10:26:26 AM,Insulet’s Strong International Performance and Optimistic Type 2 Diabetes Market Outlook Drive Positive Analyst Rating,TipRanks,/news/stocks/insulet-s-strong-international-performance-and-optimistic-type-2-diabetes-market-outlook-drive-positive-analyst-rating-1034129468,negative,0.9485438466072083
406,12/12/2024 12:06:01 PM,J.P. Morgan Keeps Their Buy Rating on Insulet (PODD),TipRanks,/news/stocks/j-p-morgan-keeps-their-buy-rating-on-insulet-podd-1034130572,positive,0.9158788919448853
407,12/20/2024 5:10:19 PM,"DexCom, Insulet, Tandem benefit from Novo Nordisk CagriSema data",Seeking Alpha,https://seekingalpha.com/news/4389338-dexcom-insulet-tandem-benefit-novo-nordisk-cagrisema-data?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7844442129135132
408,12/20/2024 8:38:54 PM,"Biggest stock movers Friday: RGTI, CCL, NVO, DXCM and more",Seeking Alpha,https://seekingalpha.com/news/4388947-biggest-stock-movers-friday-fdx-x-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9151267409324646
409,12/30/2024 10:55:05 AM,BTIG Sticks to Their Buy Rating for Insulet (PODD),TipRanks,/news/stocks/btig-sticks-to-their-buy-rating-for-insulet-podd-1034179450,positive,0.8422360420227051
410,12/30/2024 12:15:15 PM,Insulet price target raised to $300 from $270 at BTIG,TipRanks,/news/stocks/insulet-price-target-raised-to-300-from-270-at-btig-1034180082,negative,0.9460301399230957
411,1/3/2025 4:15:08 AM,TD Cowen Reaffirms Their Buy Rating on Insulet (PODD),TipRanks,/news/stocks/td-cowen-reaffirms-their-buy-rating-on-insulet-podd-1034188943,positive,0.8175930976867676
412,1/3/2025 10:15:19 AM,Insulet price target raised to $324 from $264 at TD Cowen,TipRanks,/news/stocks/insulet-price-target-raised-to-324-from-264-at-td-cowen-1034189831,negative,0.9483551383018494
413,1/4/2025 8:36:35 PM,Here are J. P. Morgan’s top MedTech picks for 2025,Seeking Alpha,https://seekingalpha.com/news/4392517-j-p-morgan-top-medtech-picks-2025?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9365366101264954
414,1/7/2025 6:15:25 AM,Bank of America Securities Keeps Their Buy Rating on Insulet (PODD),TipRanks,/news/stocks/bank-of-america-securities-keeps-their-buy-rating-on-insulet-podd-1034198460,positive,0.9151495695114136
415,1/7/2025 9:44:46 PM,Diabetes device maker Beta Bionics files for $100M IPO,Seeking Alpha,https://seekingalpha.com/news/4393226-diabetes-device-maker-beta-bionics-files-for-100m-ipo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9081300497055054
416,1/8/2025 11:35:51 PM,Insulet price target raised to $315 from $305 at Bernstein,TipRanks,/news/stocks/insulet-price-target-raised-to-315-from-305-at-bernstein-1034208048,negative,0.9474477767944336
417,1/13/2025 9:05:22 PM,Insulet launches Omnipod 5 in five more countries in Europe,TipRanks,/news/stocks/insulet-launches-omnipod-5-in-five-more-countries-in-europe-1034223078,positive,0.8342054486274719
418,1/13/2025 10:26:27 PM,Insulet Omnipod 5 insulin system available in five more European countries,Seeking Alpha,https://seekingalpha.com/news/4394746-insulet-omnipod-5-insulin-system-available-five-more-european-countries?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8089600205421448
419,1/15/2025 11:10:13 AM,"Analysts Conflicted on These Healthcare Names: Elevance Health (ELV), Agilent (A) and Insulet (PODD)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-elevance-health-elv-agilent-a-and-insulet-podd-1034230458,neutral,0.5501057505607605
420,1/16/2025 11:28:26 AM,Citi Sticks to Their Buy Rating for Insulet (PODD),TipRanks,/news/stocks/citi-sticks-to-their-buy-rating-for-insulet-podd-1034235686,positive,0.8300467133522034
421,1/22/2025 10:09:09 PM,Beta Bionics sets terms for upsized $113M IPO,Seeking Alpha,https://seekingalpha.com/news/4397336-beta-bionics-sets-terms-for-upsized-113m-ipo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9133118987083435
422,1/28/2025 5:36:21 PM,Beta Bionics sets terms for upsized $165M IPO,Seeking Alpha,https://seekingalpha.com/news/4399530-beta-bionics-sets-terms-for-upsized-165m-ipo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9095802307128906
423,1/31/2025 11:58:33 AM,"3 Best Growth Stocks to Buy Now, 1/31/2025, According to Analysts ",TipRanks,/news/stocks/3-best-growth-stocks-to-buy-now-1-31-2025-according-to-analysts -1034295134,positive,0.7202261686325073
424,2/3/2025 12:15:51 PM,Biote announcesTerry Weber retires Bret Christensen named CEO,TipRanks,/news/stocks/biote-announcesterry-weber-retires-bret-christensen-named-ceo-1034303084,positive,0.6957398653030396
425,2/5/2025 6:15:15 PM,FDA advises diabetes device users to check alert settings,Seeking Alpha,https://seekingalpha.com/news/4403792-fda-advises-diabetes-device-users-to-check-alert-settings?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8860114812850952
